<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">NeuroImmune Pharm Ther</journal-id><journal-id journal-id-type="iso-abbrev">NeuroImmune Pharm Ther</journal-id><journal-id journal-id-type="pmc-domain-id">3965</journal-id><journal-id journal-id-type="pmc-domain">degruytersd</journal-id><journal-id journal-id-type="publisher-id">nipt</journal-id><journal-title-group><journal-title>Neuroimmune Pharmacology and Therapeutics</journal-title></journal-title-group><issn pub-type="epub">2750-6665</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>De Gruyter Funded Articles</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10696573</article-id><article-id pub-id-type="pmcid-ver">PMC10696573.1</article-id><article-id pub-id-type="pmcaid">10696573</article-id><article-id pub-id-type="pmcaiid">10696573</article-id><article-id pub-id-type="pmid">38058996</article-id><article-id pub-id-type="doi">10.1515/nipt-2023-0017</article-id><article-id pub-id-type="publisher-id">nipt-2023-0017</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Developmental outcomes with perinatal exposure (DOPE) to prescription opioids</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Flores</surname><given-names initials="A">Adrian</given-names></name><xref rid="j_nipt-2023-0017_aff_001" ref-type="aff"/><xref rid="j_nipt-2023-0017_aff_002" ref-type="aff"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nguyen</surname><given-names initials="NM">Nghi M.</given-names></name><xref rid="j_nipt-2023-0017_aff_001" ref-type="aff"/><xref rid="j_nipt-2023-0017_aff_003" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Pendyala</surname><given-names initials="G">Gurudutt</given-names></name><xref rid="j_nipt-2023-0017_aff_001" ref-type="aff"/><xref rid="j_nipt-2023-0017_aff_003" ref-type="aff"/><xref rid="j_nipt-2023-0017_aff_004" ref-type="aff"/><xref rid="j_nipt-2023-0017_aff_005" ref-type="aff"/><email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:gpendyala@unmc.edu">gpendyala@unmc.edu</email></contrib><aff id="j_nipt-2023-0017_aff_001">
<institution content-type="dept">Department of Anesthesiology</institution>, <institution content-type="university">University of Nebraska Medical Center (UNMC)</institution>, <city>Omaha</city>, <state>NE</state>, <country country="US">USA</country>
</aff><aff id="j_nipt-2023-0017_aff_002">
<institution content-type="dept">Department of Cellular and Integrative Physiology</institution>, <institution content-type="university">UNMC</institution>, <city>Omaha</city>, <state>NE</state>, <country country="US">USA</country>
</aff><aff id="j_nipt-2023-0017_aff_003">
<institution content-type="dept">Department of Genetics, Cell Biology and Anatomy</institution>, <institution content-type="university">UNMC</institution>, <city>Omaha</city>, <state>NE</state>, <country country="US">USA</country>
</aff><aff id="j_nipt-2023-0017_aff_004">
<institution content-type="university">Child Health Research Institute</institution>, <city>Omaha</city>, <state>NE</state>, <country country="US">USA</country>
</aff><aff id="j_nipt-2023-0017_aff_005">
<institution content-type="dept">National Strategic Research Institute</institution>, <institution content-type="university">UNMC</institution>, <city>Omaha</city>, <state>NE</state>, <country country="US">USA</country>
</aff></contrib-group><author-notes><corresp id="cor1"><bold>Corresponding author: Gurudutt Pendyala</bold>, <institution content-type="dept">Department of Anesthesiology</institution>, <institution content-type="university">University of Nebraska Medical Center (UNMC)</institution>, <city>Omaha</city>, <state>NE</state><addr-line>68198-4455</addr-line>, <country country="US">USA</country>; <institution content-type="dept">Department of Genetics, Cell Biology and Anatomy</institution>, <institution content-type="university">UNMC</institution>, <city>Omaha</city>, <state>NE</state><addr-line>68198</addr-line>, <country country="US">USA</country>; <institution content-type="university">Child Health Research Institute</institution>, <city>Omaha</city>, <state>NE</state><addr-line>68198</addr-line>, <country country="US">USA</country>; and <institution content-type="dept">National Strategic Research Institute</institution>, <institution content-type="university">UNMC</institution>, <city>Omaha</city>, <state>NE</state><addr-line>68198</addr-line>, <country country="US">USA</country>, Phone: <phone>+402-559-8690</phone>, E-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:gpendyala@unmc.edu">gpendyala@unmc.edu</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>11</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2023</year></pub-date><volume>2</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">450343</issue-id><fpage>339</fpage><lpage>351</lpage><history><date date-type="received"><day>20</day><month>9</month><year>2023</year></date><date date-type="accepted"><day>7</day><month>11</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>05</day><month>12</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>06</day><month>12</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-14 13:25:14.740"><day>14</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 the author(s), published by De Gruyter, Berlin/Boston</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>the author(s), published by De Gruyter, Berlin/Boston GmbH, Berlin/Boston</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under the Creative Commons Attribution 4.0 International License.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nipt-2-4-nipt-2023-0017.pdf"/><abstract><title>Abstract</title><p>Researchers have found considerable evidence in the past 20 years that perinatal opioid exposure leads to an increased risk of developmental disorders in offspring that persist into adulthood. The use of opioids to treat pain concerning pregnancy, delivery, and postpartum complications has been rising. As a result, communities have reported a 300&#8211;400&#8239;% increase in Neonatal Opioid Withdrawal Syndrome (NOWS). NOWS represents the initial stage of several behavioral, phenotypic, and synaptic deficits. This review article summarizes the Developmental Outcomes of Perinatal Exposure (DOPE) to prescription opioids. Moreover, we also seek to connect these findings to clinical research that describes DOPE at multiple stages of life. Since specific mechanisms that underlie DOPE remain unclear, this article aims to provide a framework for conceptualizing across all ages and highlight the implications they may have for longevity.</p></abstract><kwd-group><title>Keywords</title><kwd>perinatal</kwd><kwd>prescription opioids</kwd><kwd>epidemiology</kwd><kwd>preclinical</kwd><kwd>neurobehavior</kwd></kwd-group><funding-group><award-group id="award-grp1" award-type="grant"><funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://dx.doi.org/10.13039/100000026">National Institute on Drug Abuse</funding-source><award-id>DA046852,DA049577, DA059177,DA058588</award-id><award-id>DA046852-4S1</award-id></award-group><award-group id="award-grp2" award-type="grant"><funding-source>Department of Anesthesiology startup funds</funding-source></award-group><award-group id="award-grp3" award-type="grant"><funding-source>Lieberman Endowment</funding-source></award-group></funding-group><counts><fig-count count="3"/><ref-count count="120"/><page-count count="13"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="j_nipt-2023-0017_s_001"><title>Overview of opioids</title><p>Opioid receptors are a diverse class of receptors, consisting of the kappa opioid receptor (KOR), mu-opioid receptor (MOR), delta-opioid receptor (DOR), and Orphan Q. The distribution of these receptors is equally diverse, forming distinct niches across the body. Primarily located in the central nervous system and periphery [<xref rid="j_nipt-2023-0017_ref_001" ref-type="bibr">1</xref>], most of which are in the gut [<xref rid="j_nipt-2023-0017_ref_002" ref-type="bibr">2</xref>]. The function of the receptors is even more diverse, ranging from control of growth to excretion. However, this review will focus on those functions crucial to the general use and abuse of opioids. In the generalized signaling pathway pertinent to use and abuse, exogenous opioids depolarize neurons in the brain to lower the excitability of synapses responsible for pain sensation nociception [<xref rid="j_nipt-2023-0017_ref_003" ref-type="bibr">3</xref>, <xref rid="j_nipt-2023-0017_ref_004" ref-type="bibr">4</xref>]. Pain relief is a crucial function to aid in survival following physical [<xref rid="j_nipt-2023-0017_ref_005" ref-type="bibr">5</xref>] and emotional trauma to some extent [<xref rid="j_nipt-2023-0017_ref_006" ref-type="bibr">6</xref>, <xref rid="j_nipt-2023-0017_ref_007" ref-type="bibr">7</xref>]. Using this signaling pathway, scientists have developed agonists to help manage pain.</p><p>Prolonged use of opioids is known to lower the regulation of crucial neurotransmission in the limbic system. A summary of downstream signaling affected by opioids is shown in <xref rid="j_nipt-2023-0017_fig_001" ref-type="fig">Figure 1</xref>. Opioid receptors are G Protein-Coupled Receptors (GPCRSs) with the potential to cause downstream alteration through &#946;-arrestin signaling, such as phosphorylation of kinases, changes in NMDA receptor composition and activity, and purinergic receptor activity in microglia [<xref rid="j_nipt-2023-0017_ref_002" ref-type="bibr">2</xref>]. Presynaptic kinase disruption can lead to impairments in calcium signaling and changes in vesicle loading via changes in calmodulin and CAMKII [<xref rid="j_nipt-2023-0017_ref_008" ref-type="bibr">8</xref>]. Furthermore, opioid-dependent alteration to NMDA receptors is pivotal in maintaining ion concentration at the postsynaptic terminal [<xref rid="j_nipt-2023-0017_ref_009" ref-type="bibr">9</xref>]. These changes were found to contribute to excitatory changes in the limbic system that are a part of the addictive properties, possibly influencing the impulsivity of users [<xref rid="j_nipt-2023-0017_ref_010" ref-type="bibr">10</xref>].</p><fig position="float" id="j_nipt-2023-0017_fig_001" fig-type="figure" orientation="portrait"><label>Figure 1:</label><caption><p>Common conserved binding element of opioids of focus, simplified downstream signaling mechanisms. Generated using <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://biorender.com" ext-link-type="uri">biorender.com</ext-link>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="j_nipt-2023-0017_fig_001.jpg"/></fig><p>Recently, scientists have expanded their understanding of the opioid receptor&#8217;s impact to include the immune system [<xref rid="j_nipt-2023-0017_ref_011" ref-type="bibr">11</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_014" ref-type="bibr">14</xref>]. Acutely, opioids such as morphine are shown to blunt inflammatory responses to viral and bacterial infections, as shown in models using empty viral vectors and L.P.S. injections [<xref rid="j_nipt-2023-0017_ref_015" ref-type="bibr">15</xref>]. Researchers have found opioids such as morphine and oxycodone allosterically bind to Toll-like receptor 4 (TLR4) on T lymphocytes and B cells by interacting with myeloid differentiation factor 2 (MD2) [<xref rid="j_nipt-2023-0017_ref_016" ref-type="bibr">16</xref>]. MD2 is essential to differentiating T regulatory cells (T regs). Natural Killer cells (NK) are also impacted by opioid exposure, demonstrating a lowered ability to trigger apoptosis [<xref rid="j_nipt-2023-0017_ref_017" ref-type="bibr">17</xref>, <xref rid="j_nipt-2023-0017_ref_018" ref-type="bibr">18</xref>]. More broadly than immunogenic properties of lymphocytes, opioid exposure has also been shown to alter the capabilities of surface-level receptors of peripheral blood mononuclear cells (PBMC)s [<xref rid="j_nipt-2023-0017_ref_019" ref-type="bibr">19</xref>, <xref rid="j_nipt-2023-0017_ref_020" ref-type="bibr">20</xref>]. Collectively, research indicates that opioids impact the development of the immune system.</p><p>For the mechanism of action, this review will focus on the effects of MOR and KOR agonism. Drugs that target these pathways are commonly abused: heroin, morphine, hydrocodone, and oxycodone. The chemical structure of these drugs is highly conserved, sharing a morphinan ring fused to a piperdine ring, key to receptor agonism. Similarly, the metabolism of these opioids follows a common pathway. The opioid requires multiple passes with CYP enzymes in the liver before they can be glucuronidated and excreted. A simplified metabolic pathway for opioids is shown in <xref rid="j_nipt-2023-0017_fig_002" ref-type="fig">Figure 2</xref>. From a pharmacodynamic and kinetic perspective, this allows adequate time for these drugs to work. Generally, CYP enzymes are highly inducible, producing significantly altered effectiveness in metabolizing other drugs (slower or more rapid metabolism). CYP induction has been shown with opioid metabolism in multiple instances [<xref rid="j_nipt-2023-0017_ref_021" ref-type="bibr">21</xref>]. This includes Gene Wide Association Studies (GWAS) showing an increased metabolism of opioids in regular users of opioids [<xref rid="j_nipt-2023-0017_ref_022" ref-type="bibr">22</xref>]. Additionally, opioids can be water or lipid-soluble, contributing to the rapid onset of each drug. In the case of our drugs of focus, commonly used analgesic opioids (morphine, buprenorphine, and oxycodone), they share a chemical structure that makes them lipophilic, allowing them rapid action and effective management of moderate and severe pain.</p><fig position="float" id="j_nipt-2023-0017_fig_002" fig-type="figure" orientation="portrait"><label>Figure 2:</label><caption><p>General opioid metabolism. Shown by example with oxycodone via oral administration. In the case of intravenous, phase one is completed more quickly, does not require absorption in the gut, and can directly interact with the liver, where all detoxification occurs. Generated using <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://Biorender.com" ext-link-type="uri">Biorender.com</ext-link>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="j_nipt-2023-0017_fig_002.jpg"/></fig><p>The latter niche (the gut) is crucial in balancing human metabolism &#8211; outside of directly inducing CYP enzymes. The gut also houses our microbiome, which plays a significant role in gastrointestinal health [<xref rid="j_nipt-2023-0017_ref_002" ref-type="bibr">2</xref>, <xref rid="j_nipt-2023-0017_ref_023" ref-type="bibr">23</xref>]. Opioids reduce the excitability of nerves in the gut, leading to changes in motility, peristalsis, and intestinal permeability [<xref rid="j_nipt-2023-0017_ref_023" ref-type="bibr">23</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_025" ref-type="bibr">25</xref>]. In recent years, scientists have become more aware of the delicate balance between gut and brain health, known as the gut-brain axis [<xref rid="j_nipt-2023-0017_ref_026" ref-type="bibr">26</xref>]. In addition to contributing to metabolism, the gut is a significant contributor of serotonin in the body, which directly communicates with the brain via the dorsal root ganglion. Researchers have found that chronic use of opioids leads to direct effects such as constipation but have also been shown to lower alpha diversity of microbiota [<xref rid="j_nipt-2023-0017_ref_027" ref-type="bibr">27</xref>], influencing gut-brain axis signaling. Scientists have also identified microbiota directly contributing to host immunity [<xref rid="j_nipt-2023-0017_ref_028" ref-type="bibr">28</xref>].</p><p>The metabolism and distribution of opioid receptors have predominantly been studied within the context of adult pharmacology and physiology. However, when examining the early stages of development, the complexity of opioid metabolism becomes more apparent. Researchers have utilized computational models to predict the fetal metabolism of opioids with varying degrees of success [<xref rid="j_nipt-2023-0017_ref_029" ref-type="bibr">29</xref>]. For example, computational predictions of fetal oxycodone and morphine metabolism have shown significant discrepancies when compared to clinical findings [<xref rid="j_nipt-2023-0017_ref_030" ref-type="bibr">30</xref>, <xref rid="j_nipt-2023-0017_ref_031" ref-type="bibr">31</xref>]. Notably, these investigations have revealed distinct fetal deposition and metabolism patterns for morphine and oxycodone, despite both drugs sharing common metabolic pathways in adulthood. Furthermore, researchers have yet to fully characterize the derivates of fetal opioid metabolism. Together, this highlights a significant gap in our understanding of fetal opioid metabolism.</p><p>The opioid receptor&#8217;s role in early life is complex and changes based on the stage of development and tissue type. For example, trophoblast cells, dominate in early developmental tissue, release human chorionic gonadotropin (hCG) in response to KOR signaling [<xref rid="j_nipt-2023-0017_ref_032" ref-type="bibr">32</xref>]. However, this relationship shifts in later pregnancy when endogenous opioid signaling, mediated by molecules like endorphins, suppresses hormone release [<xref rid="j_nipt-2023-0017_ref_033" ref-type="bibr">33</xref>, <xref rid="j_nipt-2023-0017_ref_034" ref-type="bibr">34</xref>]. At the villi, opioid signaling plays a significant role in blood flow [<xref rid="j_nipt-2023-0017_ref_032" ref-type="bibr">32</xref>]. Some research has indicated that exogenous administration of opioids can induce alterations in blood flow between the placenta and fetus, potentially leading to restrictions in nutrient and blood supply [<xref rid="j_nipt-2023-0017_ref_031" ref-type="bibr">31</xref>]. Some hypotheses suggest that this interaction may contribute to lower birth weight of perinatally exposed children. Additionally, research has demonstrated differences in the cellular localization of MOR and KOR in the brainstem in early life [<xref rid="j_nipt-2023-0017_ref_035" ref-type="bibr">35</xref>]. As mentioned earlier, opioids interact with TLR-4, which is immunologically active in the placenta, helping regulate immune responses [<xref rid="j_nipt-2023-0017_ref_032" ref-type="bibr">32</xref>]. In a rodent model Robertson et al., exogenous opioids have been shown to cause inflammatory changes in the placenta and fetus, possibly contributing to preterm birth [<xref rid="j_nipt-2023-0017_ref_036" ref-type="bibr">36</xref>]. In a separate rodent model, opioid receptors were significantly upregulated in the striatum in early life but were less functional than adult opioid receptors [<xref rid="j_nipt-2023-0017_ref_037" ref-type="bibr">37</xref>]. In summary, from a developmental perspective, it is clear that opioid signaling is a vital process that deviates from the functioning of opioid signaling in early development and adulthood.</p><sec id="j_nipt-2023-0017_s_001_s_001"><title>Opioid use disorder (OUD)</title><p>Opioids often induce sense of euphoria in many users. The euphoric effects of opioids have been well-documented throughout history, dating back to ancient civilization like the Greeks, often paired with a high potential for abuse and addiction. Notably, the effects of refined opiates, particularly opium, led to the addiction of millions in 19th-century China, triggering a national crisis. As mentioned earlier, opioid receptors are ubiquitous in mammalian physiology and are highly conserved.</p><p>In terms of addiction and abuse, opioids primarily work in the brain&#8217;s mesolimbic system, triggering hyperpolarization in this reward pathway. Unfortunately, the phenomenon of tolerance, which involves dose escalation, is common and rapid among opioid abusers. The danger lies in the downregulation of these receptors over time, which results in inadequate stimulation by endogenous production and necessitates dose escalation, eventually leading to the search for more potent receptor antagonists. Pharmacologists have sought to address this issue by developing more powerful opioids. As a result of the characteristics outlined here, opioids present significant physiological and psychological withdrawal symptoms.</p><p>Furthermore, tolerance and desensitization are only a few aspects of opioid use and abuse. Patients who do not manage their opioid doses correctly or engage in abuse often report hyperalgesia, experiencing significantly greater rebound pain compared to the ailment they were initially treating [<xref rid="j_nipt-2023-0017_ref_038" ref-type="bibr">38</xref>, <xref rid="j_nipt-2023-0017_ref_039" ref-type="bibr">39</xref>]. Regarding opioid-induced hyperalgesia, research has consistently shown that pain thresholds are reduced in both patients and preclinical models [<xref rid="j_nipt-2023-0017_ref_040" ref-type="bibr">40</xref>, <xref rid="j_nipt-2023-0017_ref_041" ref-type="bibr">41</xref>]. Additionally, opioids have a much broader long-term effect on neurotransmission.</p><p>In the era of modern pharmacology, synthetic opioids with potencies tens to hundreds of times greater than their historical counterparts have been developed. This paved the way for abuse of substances like heroin and morphine in the early 20th century. It is well-established that opioids have a high abuse rate and are highly addictive [<xref rid="j_nipt-2023-0017_ref_017" ref-type="bibr">17</xref>, <xref rid="j_nipt-2023-0017_ref_018" ref-type="bibr">18</xref>]. Progress did not stop at morphine, as new drugs such as oxycodone, buprenorphine, and fentanyl have emerged, each carrying its own risk of future abuse. The abuse of these highly potent psychoactive analgesics has contributed to a significant loss of life through overdoses, neuronal hyperpolarization, and impacts on brainstem functions, including breathing control. To mitigate these overdoses, opioid receptor antagonists such as naloxone and naltrexone were developed.</p><p>In 1994, the American Psychological Association (A.P.A.) updated the DSM IV to formally recognize Opioid Use Disorder (OUD), as a distinct psychiatric disorder separate from other forms of substance abuse and dependency. Several therapeutics have been developed to facilitate a cessation of opioids and mitigate withdrawal symptoms, including medications like buprenorphine and methadone. Despite these advancements, the United States (U.S.) declared the Opioid Crisis a national public health emergency in 2018 [<xref rid="j_nipt-2023-0017_ref_023" ref-type="bibr">23</xref>, <xref rid="j_nipt-2023-0017_ref_027" ref-type="bibr">27</xref>].</p></sec></sec><sec id="j_nipt-2023-0017_s_002"><title>The opioid epidemic</title><p>The use of opioids to treat chronic pain has seen a sharp increase since the late 1990s [<xref rid="j_nipt-2023-0017_ref_042" ref-type="bibr">42</xref>]. According to the Center for Disease Control (CDC) Wide-ranging Online Data for Epidemiological Research (WONDER), rates of OUD have surged by 500&#8239;% since the early 2000&#8217;s [<xref rid="j_nipt-2023-0017_ref_042" ref-type="bibr">42</xref>]. Anthropologists and sociologists attributed the start of the crisis to two main factors: (1) the misleading marketing of commonly prescribed opioids such as oxycodone to be non-habit forming [<xref rid="j_nipt-2023-0017_ref_043" ref-type="bibr">43</xref>] and (2) a campaign to make pain the &#8220;5th vital sign&#8221; [<xref rid="j_nipt-2023-0017_ref_044" ref-type="bibr">44</xref>]. Part of the campaign included marketing to physicians that when receptor desensitization and hyperalgesia occurred in patients, this was normal, and proper treatment involved doubling the opioid dose [<xref rid="j_nipt-2023-0017_ref_045" ref-type="bibr">45</xref>]. This directly contradicts anesthesiology research findings, which implied that to maintain effectiveness, dosage and pain should be closely monitored. While public awareness of the dangers of opioids has improved, recently Min&#8239;et al. utilized the FDA&#8217;s Adverse Events Reporting System to show a significant rise in OUD and overdose using an interrupted time series analysis [<xref rid="j_nipt-2023-0017_ref_046" ref-type="bibr">46</xref>]. In the past three years, the U.S. has seen significant increases in the use of recreational fentanyl, leading to a spike in overdoses [<xref rid="j_nipt-2023-0017_ref_047" ref-type="bibr">47</xref>]. The continued abuse of opioids demonstrates the lasting impact of <italic toggle="yes">The Opioid Epidemic</italic> on American culture and public health.</p><p>Developmental biologists and neuroscientists recognize that the initial crisis and overdoses represent just the beginning of the problem. In the U.S., clinics are taking enhanced measures to monitor prescription opioids such as oxycodone [<xref rid="j_nipt-2023-0017_ref_044" ref-type="bibr">44</xref>, <xref rid="j_nipt-2023-0017_ref_048" ref-type="bibr">48</xref>]. Hotspots of perinatal use reports are focused on rural communities and intercity areas [<xref rid="j_nipt-2023-0017_ref_047" ref-type="bibr">47</xref>, <xref rid="j_nipt-2023-0017_ref_049" ref-type="bibr">49</xref>]. Areas with limited resources to track the affected individuals&#8217; population suggest statistics on neonatal abstinence syndrome (NAS) incidence are conservative estimates. The next frontier will address the care and treatment of perinatally opioid-exposed children in the coming decades. To treat and care for these vulnerable populations, research must first accurately outline the developmental deficits of the offspring.</p></sec><sec id="j_nipt-2023-0017_s_003"><title>The next national health crisis</title><p>The impacts of opioids extend beyond the individuals using them, with potential implications for the next generation. Perinatal opioid use presents a growing public health concern, particularly in terms of delayed maturation in perinatally opioid-exposed (POE) offspring. Over the last 30 years in the U.S., the use of prescription opioids to manage pregnancy-related breakthrough pain has steadily increased [<xref rid="j_nipt-2023-0017_ref_042" ref-type="bibr">42</xref>]. Prominent among these analgesics are opioids like buprenorphine, morphine, and oxycodone, which are crucial in various pregnancy contexts, including delivery, postoperative recovery, and managing persistent pains at home [<xref rid="j_nipt-2023-0017_ref_050" ref-type="bibr">50</xref>]. Opioid treatment is associated with the entire gestational cycle and even extending into lactation. Moreover, it is important to consider women who were using opioids to manage other symptoms before pregnancy and must continue usage throughout gestation in the actual clinical settings. It is well-established that all opioids can readily pass through the placental and fetal blood-brain barriers, accumulating in potentially harmful amounts [<xref rid="j_nipt-2023-0017_ref_051" ref-type="bibr">51</xref>]. Opioids also accumulate in biologically relevant concentrations in the breast milk of mammals during lactation [<xref rid="j_nipt-2023-0017_ref_052" ref-type="bibr">52</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_055" ref-type="bibr">55</xref>]. Importantly, all opioids have the potential to impact offspring development. Even though some opioids, such as buprenorphine, have a lower risk of OUD and overdose than oxycodone and fentanyl. However, their impact on offspring development remains understudied, particularly within perinatal opioid exposure.</p><p>To compound this knowledge gap, we know less about the impact on immune cell development in the womb and their long-term impact on the offspring. This extends to the understanding of maternal immune activity and the development of mature lymphocytes and glial cells in the brain, which are physiologically relevant to establishing a healthy synaptic environment. Furthermore, a lack of research elucidates the direct impact of chronic and acute opioid exposure on placental and uterine tissue. While opioid receptors have been linked to the regulation of endometriosis [<xref rid="j_nipt-2023-0017_ref_023" ref-type="bibr">23</xref>], their definitive role in endometriosis and female fertility remains uncertain.</p><sec id="j_nipt-2023-0017_s_003_s_001"><title>Development theory</title><p>An overarching developmental theory posits that environmental, epigenetic, or pharmacological stressors during pregnancy can alter the development of offspring, resulting in a greater risk of disorders and diseases, a concept known as Baker&#8217;s theory of development. This theory is implicated in many perinatal stressors and the uptick in mental health challenges. Generally, the perinatal stressors affect the machinery involved in PANoptosis, a collective term for cell death processes including pyroptosis, apoptosis, and necroptosis. These disruptions can adversely affect the functioning of vital organ systems, including the brain [<xref rid="j_nipt-2023-0017_ref_056" ref-type="bibr">56</xref>, <xref rid="j_nipt-2023-0017_ref_057" ref-type="bibr">57</xref>]. Such functional changes impact various aspects of physiology resulting global deficits. Specifically, several researchers have characterized deficits in immune signaling linked to gestational drug exposure (maternal immune deactivation) and maternal immune activation (M.I.A.) [<xref rid="j_nipt-2023-0017_ref_058" ref-type="bibr">58</xref>], which are associated with a greater risk of social disorders via synaptic deficits [<xref rid="j_nipt-2023-0017_ref_059" ref-type="bibr">59</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_062" ref-type="bibr">62</xref>].</p><p>Opioids, including those used by pregnant women, have the potential to disrupt the immune profiles of users, as well as their offspring. In perinatal murine models of methadone exposure, researchers found distinct inflammatory profiles of exposed offspring that persisted into adulthood [<xref rid="j_nipt-2023-0017_ref_051" ref-type="bibr">51</xref>, <xref rid="j_nipt-2023-0017_ref_058" ref-type="bibr">58</xref>, <xref rid="j_nipt-2023-0017_ref_063" ref-type="bibr">63</xref>]. This indicates that immune impairments are not exclusive to the mothers taking opioids but extend to children exposed to them. Researchers hypothesize that inflammasome activity contributes to changes in the immune environment, potentially delaying synapse development [<xref rid="j_nipt-2023-0017_ref_064" ref-type="bibr">64</xref>]. In addition to these direct impairments, researchers have recently found POE to lead to microbiome dysbiosis in the dam and offspring [<xref rid="j_nipt-2023-0017_ref_023" ref-type="bibr">23</xref>, <xref rid="j_nipt-2023-0017_ref_027" ref-type="bibr">27</xref>]. These foundational studies provide another mechanism to elucidate immune dysfunction in offspring and alterations in their baseline immune activity.</p></sec><sec id="j_nipt-2023-0017_s_003_s_002"><title>The synapse development</title><p>Synactive theory of development is a branch of the overarching theory of developmental biology specific to synapse development [<xref rid="j_nipt-2023-0017_ref_065" ref-type="bibr">65</xref>, <xref rid="j_nipt-2023-0017_ref_066" ref-type="bibr">66</xref>]. Generally, active synapses form more permeant neural circuits that stave off synapse elimination [<xref rid="j_nipt-2023-0017_ref_067" ref-type="bibr">67</xref>, <xref rid="j_nipt-2023-0017_ref_068" ref-type="bibr">68</xref>]. Characterization includes a static timeline for neuronal, glial, and immune maturation [<xref rid="j_nipt-2023-0017_ref_069" ref-type="bibr">69</xref>]. The ability to eliminate and form synapses is also dependent on age [<xref rid="j_nipt-2023-0017_ref_070" ref-type="bibr">70</xref>, <xref rid="j_nipt-2023-0017_ref_071" ref-type="bibr">71</xref>]. The density of potential neural connections peaks in early adolescence and stabilizes in late adulthood, with a decline as people reach the geriatric stages of life [<xref rid="j_nipt-2023-0017_ref_072" ref-type="bibr">72</xref>]. Synaptic plasticity follows a similar trajectory along with learning processes [<xref rid="j_nipt-2023-0017_ref_073" ref-type="bibr">73</xref>]. A hallmark of learning is making neural connections but also eliminating superfluous connections. Pruning of synapses is well illustrated in learning new languages, where eliminating erroneous sounds is just as crucial to speaking fluency [<xref rid="j_nipt-2023-0017_ref_073" ref-type="bibr">73</xref>]. A buprenorphine model of POE found offspring experience diminished learning capacity [<xref rid="j_nipt-2023-0017_ref_074" ref-type="bibr">74</xref>, <xref rid="j_nipt-2023-0017_ref_075" ref-type="bibr">75</xref>]. This same trajectory of synapse formation is persistent among mammals such as primates and rodents. The elimination and formation of synapses are also controlled by the glial cells, such as astrocytes and microglia, through processes still under investigation.</p></sec><sec id="j_nipt-2023-0017_s_003_s_003"><title>Role of glial cells</title><p>While scientists hypothesize that glial cells and activity are a driving force of synapse maintenance, there remains a disconnection between synapse formation and its overall functional neurodevelopment. For instance, Smith et al. demonstrated the pivotal physiological role of microglia in synapse pruning by depleting microglia in adolescent mice [<xref rid="j_nipt-2023-0017_ref_064" ref-type="bibr">64</xref>]. Similarly, perinatal TLR-stimulated offspring (similar to opioid stimulation of fetal TLR) were observed to have lower microglial counts and reduced complexity, coinciding with alternations in the electrophysiological properties of neurons [<xref rid="j_nipt-2023-0017_ref_076" ref-type="bibr">76</xref>]. Furthermore, Alipio and colleagues reported hyperactive basal synapse activity and evoked responses in POE offspring during adolescence, paired with changes in learning [<xref rid="j_nipt-2023-0017_ref_052" ref-type="bibr">52</xref>, <xref rid="j_nipt-2023-0017_ref_053" ref-type="bibr">53</xref>]. Odegaard and colleagues also reported hyperactivity in the synapse, suggesting an impaired phenotype at the synaptic junction. However, works conducted by Wu and colleagues showed diminished synapse activity in the POE of buprenorphine, paired with increased depressive-like behaviors reported by reduced force swim test scores and lower reactivity of glial cells [<xref rid="j_nipt-2023-0017_ref_074" ref-type="bibr">74</xref>, <xref rid="j_nipt-2023-0017_ref_077" ref-type="bibr">77</xref>]. In another study by Flores and colleagues, <italic toggle="yes">in utero oxycodone exposed offspring</italic> (IUO)-offspring displayed lower astrocyte markers in PFC-derived synaptosomes in an oxycodone model [<xref rid="j_nipt-2023-0017_ref_078" ref-type="bibr">78</xref>]. Taken together, the evidence suggests perinatal opioid exposure limits the glial cell&#8217;s ability to coordinate neuron growth and refining, leading to challenges in cognition.</p><p>Aside from potential developmental challenges, POE has the potential to be more susceptible to viral and bacterial infections. Newville and colleagues found that POE primes the peripheral immune system toward hyperactivity using an <italic toggle="yes">ex vivo</italic> approach [<xref rid="j_nipt-2023-0017_ref_079" ref-type="bibr">79</xref>]. Researchers have also seen significant evidence that microglia are active as viral reservoirs of pathogens such as HIV and COVID [<xref rid="j_nipt-2023-0017_ref_080" ref-type="bibr">80</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_082" ref-type="bibr">82</xref>]. Specifically, buprenorphine is associated with increased infectivity of HIV in clinical evaluations of patient PBMCs [<xref rid="j_nipt-2023-0017_ref_083" ref-type="bibr">83</xref>]. As mentioned, PCR of brain tissue in POE offspring demonstrated a distinct phenotype with altered reactivity to nicotine, a typically neuroprotective substance [<xref rid="j_nipt-2023-0017_ref_084" ref-type="bibr">84</xref>]. However, research has yet to characterize the reactivity of these cells to viral or bacterial infection. This raises the question: are POE offspring&#8217;s microglia more amenable to high viral loads or more susceptible to HIV-associated neurocognitive disorders (HAND) or long-term COVID-19?</p></sec></sec><sec id="j_nipt-2023-0017_s_004"><title>Neonatal opioid withdrawal syndrome (NOWS)</title><p>Neonatal opioid withdrawal syndrome (NOWS) serves as a critical starting point for understanding the developmental outcomes with perinatal exposure (DOPE). This condition arises in children born to mothers who used opioids during pregnancy. This short window following delivery and feeding is enough to trigger withdrawal [<xref rid="j_nipt-2023-0017_ref_051" ref-type="bibr">51</xref>] in these offspring as they are accustomed to a continuous supply of opioids through the umbilical cord. The severity of withdrawal determines the level of care required for these children, placing a significant financial burden on the healthcare system. Taxpayers often shoulder this burden, as these children frequently receive care through Medicare resources. <italic toggle="yes">In utero</italic> models of opioid exposure provide insights into NOWS, as birth disrupts the continuous flow of opioids to the offspring, leading to considerable stress to the offspring during this short transitional period.</p><p>Notably, NOWS is a public health crisis that disproportionally impacts disenfranchised communities [<xref rid="j_nipt-2023-0017_ref_085" ref-type="bibr">85</xref>]. The rates of NOWS and NAS in the U.S. vary based on socioeconomic factors. For example, rural areas and minority populations report having 4&#8211;5 times NOWS cases. These disparities varied from access to treatment for use disorders and the level of maternal care routinely available to perinatal women. This includes the quality of communication between physicians and patients, which has been declining in the face of growing strains on healthcare systems and varies based on patients&#8217; backgrounds [<xref rid="j_nipt-2023-0017_ref_086" ref-type="bibr">86</xref>].</p><p>Assessments for NOWS and neonatal abstinence syndrome (NAS) are in the early stages of development. Two prominent empirical methods for scoring the severity of NOWS and NAS are The Finnegan Neonatal Abstinence Scoring System (FNASS) and the Eat Sleep Console System (ESC) [<xref rid="j_nipt-2023-0017_ref_087" ref-type="bibr">87</xref>, <xref rid="j_nipt-2023-0017_ref_088" ref-type="bibr">88</xref>]. These scoring systems have demonstrated their effectiveness in reducing the severity of infant stays in the Neonatal Intensive Care Unit (NICU) by providing crucial information to physicians about infant needs. However, these models of care are not standardized between NICUs. Thus, POE children often receive inadequate healthcare services within our current system.</p><p>While FNASS and ESC form an initial framework for pediatricians and psychiatrists to assess and treat infants, their utility is limited to the first few months. Importantly, the Diagnostic and Statistical Manual (DSM) includes OUD but lacks criteria for NAS and DOPE. This gap in behavioral sciences complicates tracking children&#8217;s development within the DOPE spectrum and underestimates affected populations. This paper seeks to bridge these gaps and advocate for DOPE&#8217;s inclusion in future DSM versions.</p><p>Clinical scientists have employed neuroimaging to demonstrate persistent differences in brain volumes of the frontal cortex, hippocampus, and amygdala definition in children with perinatal opioid exposure, which are critical for executive functions [<xref rid="j_nipt-2023-0017_ref_089" ref-type="bibr">89</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_091" ref-type="bibr">91</xref>]. Simultaneously, researchers denote changes in limbic connectivity in children with POE through voxel-wise analyses [<xref rid="j_nipt-2023-0017_ref_092" ref-type="bibr">92</xref>]. Epidemiological data suggest an increased risk of psychiatric disorders, such as attention deficit disorder, in these children. Addressing the existing gap in clinical data is essential to comprehensively cover structural and connectivity changes in adolescents and adults exposed to opioids.</p><sec id="j_nipt-2023-0017_s_004_s_001"><title>General behavioral deficits</title><p>Beyond the cognitive implications, preclinical POE models have shed light on a range of behavioral deficits in offspring, including anxiety-like behaviors, depressive-like indicators, and analgesic deficits [<xref rid="j_nipt-2023-0017_ref_093" ref-type="bibr">93</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_096" ref-type="bibr">96</xref>]. Among these, the most extensively studied deficit is anxiety-like behavior, which assessed through various assays such as open field, startle response, elevated plus maze, marble bury assay, and novel environment testing [<xref rid="j_nipt-2023-0017_ref_097" ref-type="bibr">97</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_102" ref-type="bibr">102</xref>]. Persistent changes to analgesic tolerance were also observed in POE offspring, as indicated by hot plate, tail flick, and Von Frey assays. As mentioned earlier, POE offspring exhibit notably lower scores in forced swim tests, a decrease in social drive, and depressive-like indicators. Additionally, studies on vocalizations in basal and social testing settings have revealed altered stress tolerance and maternal interactions in POE offspring [<xref rid="j_nipt-2023-0017_ref_103" ref-type="bibr">103</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_106" ref-type="bibr">106</xref>]. The implications of these findings extend beyond the individual and may involve factors such as maternal care or offspring brain connectivity.</p><p>Altered maternal care has been a concern among preclinical researchers, yet limited research has employed cross-fostering of POE offspring to disentangle direct causality in POE deficits. A search on PubMed and Google Scholar yielded only eight research articles addressing this limitation in perinatal research of analgesics, with just six articles focusing on opioids&#8211;none of which studied the impact of oxycodone [<xref rid="j_nipt-2023-0017_ref_107" ref-type="bibr">107</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_114" ref-type="bibr">114</xref>]. Separate investigations focused on maternal care, outside of cross-fostering, found no significant difference in pup retrieval, which serves as a proxy for maternal care, between POE dams and control dams [<xref rid="j_nipt-2023-0017_ref_096" ref-type="bibr">96</xref>]. However, some other researchers found differences in vocalizations between dams, and the translational significance of these differences remains uncertain. These cross-fostering studies were further categorized into two prevailing influences on offspring well-being: (1) pre- and post-natal opioid exposure, and (2) maternal care. These studies provided a foundation for further investigation, noting differences between specific cross-fostering, including broad physiology and changes in the level of neurotransmitters.</p><p>Current research of pre- and post-natal opioid-exposed offspring in murine models suggests that these offspring are primed for unique developmental challenges. POE has been linked to behavioral deficits in stress tolerance at different stages of life, from early life to adulthood [<xref rid="j_nipt-2023-0017_ref_052" ref-type="bibr">52</xref>, <xref rid="j_nipt-2023-0017_ref_053" ref-type="bibr">53</xref>, <xref rid="j_nipt-2023-0017_ref_115" ref-type="bibr">115</xref>]. Furthermore, the timing of exposure has been shown to significantly influence the extent of deficits. For example, work performed by Smith and colleagues found robust sex-based differences in social behaviors among POE offspring exposed to morphine <italic toggle="yes">in utero</italic> [<xref rid="j_nipt-2023-0017_ref_054" ref-type="bibr">54</xref>]. Flores and colleagues have demonstrated that timing of exposure is crucial, with opioid exposure during the third trimester resulting in the most severe behavioral deficits in offspring compared to prenatal and continuous exposure [<xref rid="j_nipt-2023-0017_ref_078" ref-type="bibr">78</xref>].</p><p>It is also important to consider the challenges faced by children born needing surgery and treated with intravenous opioids for extended periods, commonly referred to as postnatally exposed individuals. These children often require more aggressive treatments, such as fentanyl, which has been associated with significant developmental deficits [<xref rid="j_nipt-2023-0017_ref_015" ref-type="bibr">15</xref>, <xref rid="j_nipt-2023-0017_ref_052" ref-type="bibr">52</xref>, <xref rid="j_nipt-2023-0017_ref_053" ref-type="bibr">53</xref>, <xref rid="j_nipt-2023-0017_ref_115" ref-type="bibr">115</xref>]. Furthermore, these children may experience neonatal opioid withdrawal syndrome (NOWS), a topic of investigation by multiple researchers, revealing unique alterations in preclinical models [<xref rid="j_nipt-2023-0017_ref_052" ref-type="bibr">52</xref>, <xref rid="j_nipt-2023-0017_ref_053" ref-type="bibr">53</xref>, <xref rid="j_nipt-2023-0017_ref_074" ref-type="bibr">74</xref>, <xref rid="j_nipt-2023-0017_ref_093" ref-type="bibr">93</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_095" ref-type="bibr">95</xref>, <xref rid="j_nipt-2023-0017_ref_106" ref-type="bibr">106</xref>, <xref rid="j_nipt-2023-0017_ref_115" ref-type="bibr">115</xref>&#8211;<xref rid="j_nipt-2023-0017_ref_118" ref-type="bibr">118</xref>]. The growing epidemic of opioid use represents a pressing public health crisis, for which clinicians currently lack research-driven guidelines.</p><p>In addition to highlighting the significance of timing in offspring deficits, Flores et al. identified substantial evidence of sex-based alterations in body sizes and social behavior [<xref rid="j_nipt-2023-0017_ref_078" ref-type="bibr">78</xref>]. It&#8217;s worth noting that sex effects have been extensively documented in the field of drug abuse. Smith et al. also found sex-based behavioral differences in POE offspring. However, no studies have specifically focused on elucidating sex-based differences in both physiology and behavioral changes among POE offspring.</p><p>Odegaard and colleagues have conducted comparative analyses of pre- and post-natally oxycodone-exposed offspring from early life to adulthood, highlighting the persistence of behavioral deficits [<xref rid="j_nipt-2023-0017_ref_095" ref-type="bibr">95</xref>]. Given the longer human gestational period compared to rodents, the impact of opioid exposure during the prenatal and early postnatal phases is more pronounced. Their chronic oxycodone model demonstrated significant and persistent anxiety-like effects in both pre-and postnatal oxycodone-exposed offspring, as indicated by behaviors such as marble burying during early life persisting into adulthood. These studies revealed that the severity of these impacts is influenced by the duration and timing of opioid exposure, with acutely exposed offspring experiencing more substantial and enduring deficits. Additionally, Flores and colleagues presented data from early adolescence using the same oxycodone exposure models, highlighting the significantly impaired sociability and responses to environmental stress compared to social stress among exposed offspring [<xref rid="j_nipt-2023-0017_ref_078" ref-type="bibr">78</xref>, <xref rid="j_nipt-2023-0017_ref_084" ref-type="bibr">84</xref>]. A summary of DOPE impacts is shown in <xref rid="j_nipt-2023-0017_fig_003" ref-type="fig">Figure 3</xref>.</p><fig position="float" id="j_nipt-2023-0017_fig_003" fig-type="figure" orientation="portrait"><label>Figure 3:</label><caption><p>Overview of DOPE. Graphic summary of significant deficits found in using molecular, synaptic, and behavioral deficits observed in offspring. Generated using <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://biorender.com" ext-link-type="uri">biorender.com</ext-link>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="j_nipt-2023-0017_fig_003.jpg"/></fig></sec></sec><sec id="j_nipt-2023-0017_s_005"><title>The perspective of future offspring investigation</title><p>One critical knowledge gap pertains to the cumulative impact of added life stresses on POE offspring. While recent research by Flores et al. has indicated that nicotine and other low-dose stimulants may not cause immediate harm to adolescent-exposed offspring, their vulnerability to other psychoactive substances like alcohol, anesthetics, and future analgesic use remains poorly understood [<xref rid="j_nipt-2023-0017_ref_084" ref-type="bibr">84</xref>]. These substances have been implicated in recent bioinformatics studies focused on the transcriptional and translational level [<xref rid="j_nipt-2023-0017_ref_054" ref-type="bibr">54</xref>, <xref rid="j_nipt-2023-0017_ref_078" ref-type="bibr">78</xref>, <xref rid="j_nipt-2023-0017_ref_095" ref-type="bibr">95</xref>, <xref rid="j_nipt-2023-0017_ref_096" ref-type="bibr">96</xref>]. However, comprehensive investigations into the susceptibility of POE offspring to future substance use, using methods such as self-administration or preference testing are lacking. Notably, perinatal heroin exposure has been shown to induce enhanced self-administration in offspring, but the patterns of administration of commonly abused substances like prescription opioids, alcohol, and caffeine remain unknown.</p><p>Gowen and colleagues have recently also shown that POE offspring are more susceptible to mild traumatic brain injury (mTBI) using a robust rotational brain injury model in conjunction with prenatal opioid exposure [<xref rid="j_nipt-2023-0017_ref_096" ref-type="bibr">96</xref>]. This study also revealed that mTBI exacerbated injury-related changes in immune profiles and oxidative stress at the mitochondrial level, finding dysfunction in multiple complexes in the electron transport chain. However, this study primarily focused on mTBI induced in early life, and further work is needed to confirm the persistence of changes in offspring recovery profiles.</p><p>Another unexplored area relates to the consequences of intergenerational exposure on offspring. Although preliminary characterizations of F2 offspring behavior have been conducted by Odegaard and colleagues, no mechanistic validation for F2 deficits has been established [<xref rid="j_nipt-2023-0017_ref_094" ref-type="bibr">94</xref>]. These studies mainly emphasized maternal influences of opioid exposure, with a lack of male subjects to form the F2 generation through mating. The omission of male heritability as a mechanism for deficits is a notable limitation in all existing POE models.</p><p>Despite recent advancements in our knowledge regarding the early stages of POE offspring, significant gaps persist. Little is known regarding the geriatric pathology of these offspring and whether their longevity is affected in the long term. Specifically, it remains unclear whether these populations are more susceptible to degenerative neurological diseases like Alzheimer&#8217;s or other forms of dementia furthermore, while research on HIV/AIDS has garnered substantial funding, addiction studies, including POE research, have received considerably less support. In fact, addiction studies receive only a fraction of the funding allocated to HIV/AIDS research [<xref rid="j_nipt-2023-0017_ref_119" ref-type="bibr">119</xref>], resulting in a lack of investments in the study of significantly aged POE offspring.</p></sec><sec id="j_nipt-2023-0017_s_006"><title>Conclusions</title><p>The Opioid Epidemic has sparked a new public health crisis, particularly concerning the care of perinatally opioid-exposed children. While progress has been made in characterizing baseline deficits, significant knowledge gaps persist. Adolescence, a period of high neuroplasticity and habit formation, remains poorly understood, leaving critical intersections unexplored. Moreover, comprehensive insights are lacking into the potential effects of future drug use, traumatic experiences, social stress, and brain injuries on these populations.</p></sec></body><back><fn-group><fn id="j_nipt-2023-0017_fn_001" fn-type="other"><p>
<bold>Research ethics:</bold> The local Institutional Review Board deemed the study exempt from review.</p></fn><fn id="j_nipt-2023-0017_fn_002" fn-type="other"><p>
<bold>Informed consent:</bold> Not applicable.</p></fn><fn id="j_nipt-2023-0017_fn_003" fn-type="con"><p>
<bold>Author contributions:</bold> AF: investigation; writing &#8211; original draft; MN: investigation; writing &#8211; review and editing. GP: funding acquisition; project administration; supervision; writing &#8211; review and editing.</p></fn><fn id="j_nipt-2023-0017_fn_004" fn-type="COI-statement"><p>
<bold>Competing interests:</bold> The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.</p></fn><fn id="j_nipt-2023-0017_fn_005" fn-type="financial-disclosure"><p>
<bold>Research funding:</bold> This work was supported by N.I.H. grants DA046852, DA049577, DA059177, DA058588, Lieberman Endowment, Department of Anesthesiology startup funds to G.P. and Diversity Supplement DA046852-4S1&#8239;A.F. &amp; G.P. The funding entity played no role in the study design or its conduction.</p></fn><fn id="j_nipt-2023-0017_fn_006" fn-type="other"><p>
<bold>Data availability:</bold> All data accessed is included in this review article.</p></fn></fn-group><ref-list id="j_nipt-2023-0017_reflist_001"><title>References</title><ref id="j_nipt-2023-0017_ref_001"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wittert</surname><given-names>G</given-names></name><name name-style="western"><surname>Hope</surname><given-names>P</given-names></name><name name-style="western"><surname>Pyle</surname><given-names>D</given-names></name></person-group><article-title>Tissue distribution of opioid receptor gene expression in the rat</article-title><source>Biochem Biophys Res Commun</source><year>1996</year><volume>218</volume><fpage>877</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1996.0156</pub-id><pub-id pub-id-type="pmid">8579608</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_002"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sobczak</surname><given-names>M</given-names></name><name name-style="western"><surname>Sa&#322;aga</surname><given-names>M</given-names></name><name name-style="western"><surname>Storr</surname><given-names>MA</given-names></name><name name-style="western"><surname>Fichna</surname><given-names>J</given-names></name></person-group><article-title>Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives</article-title><source>J Gastroenterol</source><year>2014</year><volume>49</volume><fpage>24</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s00535-013-0753-x</pub-id><pub-id pub-id-type="pmid">23397116</pub-id><pub-id pub-id-type="pmcid">PMC3895212</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_003"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>J</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>J</given-names></name><name name-style="western"><surname>Liebeskind</surname><given-names>J</given-names></name></person-group><article-title>Opioid and non-opioid stress analgesia: assessment of tolerance and cross-tolerance with morphine</article-title><source>J Neurosci</source><year>1981</year><volume>1</volume><fpage>358</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1523/jneurosci.01-04-00358.1981</pub-id><pub-id pub-id-type="pmid">7264724</pub-id><pub-id pub-id-type="pmcid">PMC6564135</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_004"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornton</surname><given-names>SR</given-names></name><name name-style="western"><surname>Compton</surname><given-names>DR</given-names></name><name name-style="western"><surname>Smith</surname><given-names>FL</given-names></name></person-group><article-title>Ontogeny of mu opioid agonist anti-nociception in postnatal rats</article-title><source>Dev Brain Res</source><year>1998</year><volume>105</volume><fpage>269</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/S0165-3806(97)00185-5</pub-id><pub-id pub-id-type="pmid">9541744</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_005"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miczek</surname><given-names>KA</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>ML</given-names></name><name name-style="western"><surname>Shuster</surname><given-names>L</given-names></name></person-group><article-title>Opioid-like analgesia in defeated mice</article-title><source>Science</source><year>1982</year><volume>215</volume><fpage>1520</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1126/science.7199758</pub-id><pub-id pub-id-type="pmid">7199758</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_006"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liberzon</surname><given-names>I</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>SF</given-names></name><name name-style="western"><surname>Phan</surname><given-names>KL</given-names></name><name name-style="western"><surname>Britton</surname><given-names>JC</given-names></name><name name-style="western"><surname>Fig</surname><given-names>LM</given-names></name><name name-style="western"><surname>Bueller</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Altered central &#956;-opioid receptor binding after psychological trauma</article-title><source>Biol Psychiatr</source><year>2007</year><volume>61</volume><fpage>1030</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2006.06.021</pub-id><pub-id pub-id-type="pmid">16945349</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_007"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lanius</surname><given-names>RA</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>JE</given-names></name><name name-style="western"><surname>McKinnon</surname><given-names>MC</given-names></name><name name-style="western"><surname>Nicholson</surname><given-names>AA</given-names></name><name name-style="western"><surname>Frewen</surname><given-names>P</given-names></name><name name-style="western"><surname>Vermetten</surname><given-names>E</given-names></name><etal/></person-group><article-title>A review of the neurobiological basis of trauma-related dissociation and its relation to cannabinoid-and opioid-mediated stress response: a transdiagnostic, translational approach</article-title><source>Curr Psychiatr Rep</source><year>2018</year><volume>20</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1007/s11920-018-0983-y</pub-id><pub-id pub-id-type="pmid">30402683</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_008"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dieterle</surname><given-names>M</given-names></name><name name-style="western"><surname>Zurbriggen</surname><given-names>L</given-names></name><name name-style="western"><surname>Mauermann</surname><given-names>E</given-names></name><name name-style="western"><surname>Mercer-Chalmers-Bender</surname><given-names>K</given-names></name><name name-style="western"><surname>Frei</surname><given-names>P</given-names></name><name name-style="western"><surname>Ruppen</surname><given-names>W</given-names></name><etal/></person-group><article-title>Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II)</article-title><source>Pain</source><year>2022</year><volume>163</volume><fpage>1919</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1097/j.pain.0000000000002591</pub-id><pub-id pub-id-type="pmid">35239547</pub-id><pub-id pub-id-type="pmcid">PMC9982727</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_009"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayer</surname><given-names>ML</given-names></name><name name-style="western"><surname>Miller</surname><given-names>RJ</given-names></name></person-group><article-title>Excitatory amino acid receptors, second messengers and regulation of intracellular Ca2+ in mammalian neurons</article-title><source>Trends Pharmacol Sci</source><year>1990</year><volume>11</volume><fpage>254</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/0165-6147(90)90254-6</pub-id><pub-id pub-id-type="pmid">2166370</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_010"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elam</surname><given-names>HB</given-names></name><name name-style="western"><surname>Donegan</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>J</given-names></name><name name-style="western"><surname>Lodge</surname><given-names>DJ</given-names></name></person-group><article-title>Gestational buprenorphine exposure disrupts dopamine neuron activity and related behaviors in adulthood</article-title><source>eNeuro</source><year>2022</year><volume>9</volume><elocation-id>ENEURO.0499-0421.2022</elocation-id><pub-id pub-id-type="doi">10.1523/eneuro.0499-21.2022</pub-id><pub-id pub-id-type="pmcid">PMC9337603</pub-id><pub-id pub-id-type="pmid">35851301</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_011"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eriksson</surname><given-names>PS</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>M</given-names></name><name name-style="western"><surname>W&#229;gberg</surname><given-names>M</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>E</given-names></name><name name-style="western"><surname>R&#246;nnb&#228;ck</surname><given-names>L</given-names></name></person-group><article-title>Kappa-opioid receptors on astrocytes stimulate L-type Ca<sup>2+</sup> channels</article-title><source>Neuroscience</source><year>1993</year><volume>54</volume><fpage>401</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(93)90261-d</pub-id><pub-id pub-id-type="pmid">8393154</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_012"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Machelska</surname><given-names>H</given-names></name><name name-style="western"><surname>Celik</surname><given-names>M</given-names></name></person-group><article-title>Opioid receptors in immune and glial cells-implications for pain control</article-title><source>Front Immunol</source><year>2020</year><volume>11</volume><fpage>300</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2020.00300</pub-id><pub-id pub-id-type="pmid">32194554</pub-id><pub-id pub-id-type="pmcid">PMC7064637</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_013"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miguel-Hidalgo</surname><given-names>JJ</given-names></name></person-group><article-title>The role of glial cells in drug abuse</article-title><source>Curr Drug Abuse Rev</source><year>2009</year><volume>2</volume><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.2174/1874473710902010076</pub-id><pub-id pub-id-type="pmid">19606280</pub-id><pub-id pub-id-type="pmcid">PMC2709875</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_014"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>J</given-names></name><name name-style="western"><surname>Chao</surname><given-names>D</given-names></name><name name-style="western"><surname>Sandhu</surname><given-names>HK</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Balboni</surname><given-names>G</given-names></name><etal/></person-group><article-title>&#948;-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes</article-title><source>Br J Pharmacol</source><year>2014</year><volume>171</volume><fpage>5417</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1111/bph.12857</pub-id><pub-id pub-id-type="pmid">25052197</pub-id><pub-id pub-id-type="pmcid">PMC4294049</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_015"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pascoe</surname><given-names>JE</given-names></name><name name-style="western"><surname>Williams</surname><given-names>KL</given-names></name><name name-style="western"><surname>Mukhopadhyay</surname><given-names>P</given-names></name><name name-style="western"><surname>Rice</surname><given-names>KC</given-names></name><name name-style="western"><surname>Woods</surname><given-names>JH</given-names></name><name name-style="western"><surname>Ko</surname><given-names>MC</given-names></name></person-group><article-title>Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys</article-title><source>Psychoneuroendocrinology</source><year>2008</year><volume>33</volume><fpage>478</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2008.01.006</pub-id><pub-id pub-id-type="pmid">18325678</pub-id><pub-id pub-id-type="pmcid">PMC2443864</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_016"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oo</surname><given-names>TT</given-names></name><name name-style="western"><surname>Sumneang</surname><given-names>N</given-names></name><name name-style="western"><surname>Arunsak</surname><given-names>B</given-names></name><name name-style="western"><surname>Chunchai</surname><given-names>T</given-names></name><name name-style="western"><surname>Apaijai</surname><given-names>N</given-names></name><name name-style="western"><surname>Pratchayasakul</surname><given-names>W</given-names></name><etal/></person-group><article-title>Blocking myeloid differentiation factor 2 improves cognitive function via reducing microglia activation, neuroinflammation, brain mitochondrial dysfunction and dendritic spine loss in obese insulin-resistant rats</article-title><source>Alzheimer&#8217;s Dementia</source><year>2021</year><volume>17</volume><elocation-id>e050382</elocation-id><pub-id pub-id-type="doi">10.1002/alz.050382</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_017"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maher</surname><given-names>DP</given-names></name><name name-style="western"><surname>Walia</surname><given-names>D</given-names></name><name name-style="western"><surname>Heller</surname><given-names>NM</given-names></name></person-group><article-title>Morphine decreases the function of primary human natural killer cells by both TLR4 and opioid receptor signaling</article-title><source>Brain Behav Immun</source><year>2020</year><volume>83</volume><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2019.10.011</pub-id><pub-id pub-id-type="pmid">31626971</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_018"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gav&#233;riaux-Ruff</surname><given-names>C</given-names></name><name name-style="western"><surname>Matthes</surname><given-names>HWD</given-names></name><name name-style="western"><surname>Peluso</surname><given-names>J</given-names></name><name name-style="western"><surname>Kieffer</surname><given-names>BL</given-names></name></person-group><article-title>Abolition of morphine-immunosuppression in mice lacking the &#956;-opioid receptor gene</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>6326</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.11.6326</pub-id><pub-id pub-id-type="pmid">9600964</pub-id><pub-id pub-id-type="pmcid">PMC27678</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_019"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madurai</surname><given-names>NK</given-names></name><name name-style="western"><surname>Kitase</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hamimi</surname><given-names>S</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>SE</given-names></name><name name-style="western"><surname>Sevensky</surname><given-names>R</given-names></name><name name-style="western"><surname>Ramachandra</surname><given-names>S</given-names></name><etal/></person-group><article-title>Methadone alters the peripheral inflammatory and central immune landscape following prenatal exposure in rats</article-title><source>Adv Drug Alcohol Res</source><year>2022</year><volume>2</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.3389/adar.2022.10792</pub-id><pub-id pub-id-type="pmcid">PMC10312988</pub-id><pub-id pub-id-type="pmid">37396628</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_020"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boland</surname><given-names>JW</given-names></name><name name-style="western"><surname>Foulds</surname><given-names>GA</given-names></name><name name-style="western"><surname>Ahmedzai</surname><given-names>SH</given-names></name><name name-style="western"><surname>Pockley</surname><given-names>AG</given-names></name></person-group><article-title>A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function</article-title><source>BMJ Support Palliat Care</source><year>2014</year><volume>4</volume><fpage>357</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1136/bmjspcare-2013-000573</pub-id><pub-id pub-id-type="pmid">24644198</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_021"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saba</surname><given-names>R</given-names></name><name name-style="western"><surname>Kaye</surname><given-names>AD</given-names></name><name name-style="western"><surname>Urman</surname><given-names>RD</given-names></name></person-group><article-title>Pharmacogenomics in pain management</article-title><source>Anesthesiol Clin</source><year>2017</year><volume>35</volume><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/j.anclin.2017.01.015</pub-id><pub-id pub-id-type="pmid">28526150</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_022"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mouly</surname><given-names>S</given-names></name><name name-style="western"><surname>Bloch</surname><given-names>V</given-names></name><name name-style="western"><surname>Peoc&#8217;h</surname><given-names>K</given-names></name><name name-style="western"><surname>Houze</surname><given-names>P</given-names></name><name name-style="western"><surname>Labat</surname><given-names>L</given-names></name><name name-style="western"><surname>Ksouda</surname><given-names>K</given-names></name><etal/></person-group><article-title>Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity</article-title><source>Br J Clin Pharmacol</source><year>2015</year><volume>79</volume><fpage>967</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1111/bcp.12576</pub-id><pub-id pub-id-type="pmid">25556837</pub-id><pub-id pub-id-type="pmcid">PMC4456129</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_023"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>G</given-names></name></person-group><article-title>Pathoetiology and pathophysiology of borderline personality: role of prenatal factors, gut microbiome, mu- and kappa-opioid receptors in amygdala-PFC interactions</article-title><source>Prog Neuro Psychopharmacol Biol Psychiatr</source><year>2020</year><volume>98</volume><elocation-id>109782</elocation-id><pub-id pub-id-type="doi">10.1016/j.pnpbp.2019.109782</pub-id><pub-id pub-id-type="pmid">31689444</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_024"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wasilewski</surname><given-names>A</given-names></name><name name-style="western"><surname>Lesniak</surname><given-names>A</given-names></name><name name-style="western"><surname>Bujalska&#8208;Zadrozny</surname><given-names>M</given-names></name><name name-style="western"><surname>Sadowski</surname><given-names>B</given-names></name><name name-style="western"><surname>Fichna</surname><given-names>J</given-names></name><name name-style="western"><surname>Sacharczuk</surname><given-names>M</given-names></name></person-group><article-title>The effect of opioid agonists and antagonists on gastrointestinal motility in mice selected for high and low swim stress-induced analgesia</article-title><source>Neuro Gastroenterol Motil</source><year>2016</year><volume>28</volume><fpage>175</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1111/nmo.12704</pub-id><pub-id pub-id-type="pmid">26510904</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_025"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grider</surname><given-names>JR</given-names></name><name name-style="western"><surname>Makhlouf</surname><given-names>GM</given-names></name></person-group><article-title>Role of opioid neurons in the regulation of intestinal peristalsis</article-title><source>Am J Physiol</source><year>1987</year><volume>253</volume><fpage>G226</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.1987.253.2.G226</pub-id><pub-id pub-id-type="pmid">2887119</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_026"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bercik</surname><given-names>P</given-names></name><name name-style="western"><surname>Collins</surname><given-names>SM</given-names></name><name name-style="western"><surname>Verdu</surname><given-names>EF</given-names></name></person-group><article-title>Microbes and the gut-brain axis</article-title><source>Neuro Gastroenterol Motil</source><year>2012</year><volume>24</volume><fpage>405</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2982.2012.01906.x</pub-id><pub-id pub-id-type="pmid">22404222</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_027"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J</given-names></name><name name-style="western"><surname>Dutta</surname><given-names>R</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Vitari</surname><given-names>N</given-names></name><name name-style="western"><surname>Kolli</surname><given-names>U</given-names></name><etal/></person-group><article-title>Brief hydromorphone exposure during pregnancy sufficient to induce maternal and neonatal microbial dysbiosis</article-title><source>J Neuroimmune Pharmacol</source><year>2022</year><volume>17</volume><fpage>367</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1007/s11481-021-10019-2</pub-id><pub-id pub-id-type="pmid">34562195</pub-id><pub-id pub-id-type="pmcid">PMC10117152</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_028"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Francino</surname><given-names>MP</given-names></name></person-group><article-title>Early development of the gut microbiota and immune health</article-title><source>Pathogens</source><year>2014</year><volume>3</volume><fpage>769</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.3390/pathogens3030769</pub-id><pub-id pub-id-type="pmid">25438024</pub-id><pub-id pub-id-type="pmcid">PMC4243441</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_029"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Hoogdalem</surname><given-names>MW</given-names></name><name name-style="western"><surname>Wexelblatt</surname><given-names>SL</given-names></name><name name-style="western"><surname>Akinbi</surname><given-names>HT</given-names></name><name name-style="western"><surname>Vinks</surname><given-names>AA</given-names></name><name name-style="western"><surname>Mizuno</surname><given-names>T</given-names></name></person-group><article-title>A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome</article-title><source>Pharmacol Therapeut</source><year>2022</year><volume>234</volume><elocation-id>108045</elocation-id><pub-id pub-id-type="doi">10.1016/j.pharmthera.2021.108045</pub-id><pub-id pub-id-type="pmid">34813863</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_030"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shum</surname><given-names>S</given-names></name><name name-style="western"><surname>Isoherranen</surname><given-names>N</given-names></name></person-group><article-title>Human fetal liver metabolism of oxycodone is mediated by CYP3A7</article-title><source>AAPS J</source><year>2021</year><volume>23</volume><fpage>24</fpage><pub-id pub-id-type="doi">10.1208/s12248-020-00537-x</pub-id><pub-id pub-id-type="pmid">33438174</pub-id><pub-id pub-id-type="pmcid">PMC8106324</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_031"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garland</surname><given-names>M</given-names></name><name name-style="western"><surname>Abildskov</surname><given-names>KM</given-names></name><name name-style="western"><surname>Kiu</surname><given-names>TW</given-names></name><name name-style="western"><surname>Daniel</surname><given-names>SS</given-names></name><name name-style="western"><surname>Stark</surname><given-names>RI</given-names></name></person-group><article-title>The contribution of fetal metabolism to the disposition of morphine</article-title><source>Drug Metab Dispos</source><year>2005</year><volume>33</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1124/dmd.104.001388</pub-id><pub-id pub-id-type="pmid">15494471</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_032"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cemerikic</surname><given-names>B</given-names></name><name name-style="western"><surname>Zamah</surname><given-names>R</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>MS</given-names></name></person-group><article-title>Identification of L-type calcium channels associated with kappa opioid receptors in human placenta</article-title><source>J Mol Neurosci</source><year>1998</year><volume>10</volume><fpage>261</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/BF02761779</pub-id><pub-id pub-id-type="pmid">9770647</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_033"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenfeld</surname><given-names>CS</given-names></name></person-group><article-title>The placenta as a target of opioid drugs</article-title><source>Biol Reprod</source><year>2022</year><volume>106</volume><fpage>676</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioac003</pub-id><pub-id pub-id-type="pmid">35024817</pub-id><pub-id pub-id-type="pmcid">PMC9040663</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_034"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnea</surname><given-names>ER</given-names></name><name name-style="western"><surname>Ashkenazy</surname><given-names>R</given-names></name><name name-style="western"><surname>Tal</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kol</surname><given-names>S</given-names></name><name name-style="western"><surname>Sarne</surname><given-names>Y</given-names></name></person-group><article-title>Effect of beta-endorphin on human chorionic gonadotrophin secretion by placental explants</article-title><source>Hum Reprod</source><year>1991</year><volume>6</volume><fpage>1327</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.humrep.a137534</pub-id><pub-id pub-id-type="pmid">1661290</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_035"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kivell</surname><given-names>BM</given-names></name><name name-style="western"><surname>Day</surname><given-names>DJ</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Miller</surname><given-names>JH</given-names></name></person-group><article-title>Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats</article-title><source>Brain Res Dev Brain Res</source><year>2004</year><volume>149</volume><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.devbrainres.2003.11.012</pub-id><pub-id pub-id-type="pmid">15013624</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_036"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robertson</surname><given-names>SA</given-names></name><name name-style="western"><surname>Hutchinson</surname><given-names>MR</given-names></name><name name-style="western"><surname>Rice</surname><given-names>KC</given-names></name><name name-style="western"><surname>Chin</surname><given-names>P</given-names></name><name name-style="western"><surname>Moldenhauer</surname><given-names>LM</given-names></name><name name-style="western"><surname>Stark</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injury</article-title><source>Clin Transl Immunol</source><year>2020</year><volume>9</volume><fpage>e1121</fpage><pub-id pub-id-type="doi">10.1002/cti2.1121</pub-id><pub-id pub-id-type="pmcid">PMC7156293</pub-id><pub-id pub-id-type="pmid">32313651</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_037"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talbot</surname><given-names>JN</given-names></name><name name-style="western"><surname>Happe</surname><given-names>HK</given-names></name><name name-style="western"><surname>Murrin</surname><given-names>LC</given-names></name></person-group><article-title>Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain</article-title><source>J Pharmacol Exp Ther</source><year>2005</year><volume>314</volume><fpage>596</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1124/jpet.104.082156</pub-id><pub-id pub-id-type="pmid">15860573</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_038"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yalcin</surname><given-names>I</given-names></name><name name-style="western"><surname>Charlet</surname><given-names>A</given-names></name><name name-style="western"><surname>Freund-Mercier</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Barrot</surname><given-names>M</given-names></name><name name-style="western"><surname>Poisbeau</surname><given-names>P</given-names></name></person-group><article-title>Differentiating thermal allodynia and hyperalgesia using dynamic hot and cold plate in rodents</article-title><source>J Pain</source><year>2009</year><volume>10</volume><fpage>767</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2009.01.325</pub-id><pub-id pub-id-type="pmid">19409860</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_039"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deuis</surname><given-names>JR</given-names></name><name name-style="western"><surname>Dvorakova</surname><given-names>LS</given-names></name><name name-style="western"><surname>Vetter</surname><given-names>I</given-names></name></person-group><article-title>Methods used to evaluate pain behaviors in rodents</article-title><source>Front Mol Neurosci</source><year>2017</year><volume>10</volume><fpage>284</fpage><pub-id pub-id-type="doi">10.3389/fnmol.2017.00284</pub-id><pub-id pub-id-type="pmid">28932184</pub-id><pub-id pub-id-type="pmcid">PMC5592204</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_040"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wala</surname><given-names>EP</given-names></name><name name-style="western"><surname>Sloan</surname><given-names>PA</given-names></name><name name-style="western"><surname>Holtman Jr</surname><given-names>JR</given-names></name></person-group><article-title>Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats</article-title><source>J Opioid Manag</source><year>2011</year><volume>7</volume><fpage>377</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.5055/jom.2010.0079</pub-id><pub-id pub-id-type="pmid">22165037</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_041"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koponen</surname><given-names>ME</given-names></name><name name-style="western"><surname>Forget</surname><given-names>P</given-names></name></person-group><article-title>Pharmacological interventions for opioid-induced hyperalgesia: a scoping review of preclinical trials</article-title><source>J Clin Med</source><year>2022</year><volume>11</volume><pub-id pub-id-type="doi">10.3390/jcm11237060</pub-id><pub-id pub-id-type="pmcid">PMC9735807</pub-id><pub-id pub-id-type="pmid">36498635</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_042"><label>42.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>United States Department of Health and Human Services (US DHHS), C. f. D. C. a. P. C., National Center for Health Statistics (NCHS)</collab></person-group><publisher-name>CDC</publisher-name><year>2021</year><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://wonder.cdc.gov/mcd.html" ext-link-type="uri">https://wonder.cdc.gov/mcd.html</ext-link><source>.</source></element-citation></ref><ref id="j_nipt-2023-0017_ref_043"><label>43.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Meier</surname><given-names>B</given-names></name></person-group><source>Pain killer: A &#8220;wonder&#8221; drug&#8217;s trail of addiction and death</source><publisher-name>Rodale</publisher-name><year>2003</year></element-citation></ref><ref id="j_nipt-2023-0017_ref_044"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chisholm-Burns</surname><given-names>MA</given-names></name><name name-style="western"><surname>Spivey</surname><given-names>CA</given-names></name><name name-style="western"><surname>Sherwin</surname><given-names>E</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>J</given-names></name><name name-style="western"><surname>Hohmeier</surname><given-names>K</given-names></name></person-group><article-title>The opioid crisis: origins, trends, policies, and the roles of pharmacists</article-title><source>Am J Health Syst Pharm</source><year>2019</year><volume>76</volume><fpage>424</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1093/ajhp/zxy089</pub-id><pub-id pub-id-type="pmid">31361827</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_045"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valentino</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></name></person-group><article-title>Untangling the complexity of opioid receptor function</article-title><source>Neuropsychopharmacology</source><year>2018</year><volume>43</volume><fpage>2514</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/s41386-018-0225-3</pub-id><pub-id pub-id-type="pmid">30250308</pub-id><pub-id pub-id-type="pmcid">PMC6224460</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_046"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Min</surname><given-names>J</given-names></name><name name-style="western"><surname>Osborne</surname><given-names>V</given-names></name><name name-style="western"><surname>Kowalski</surname><given-names>A</given-names></name><name name-style="western"><surname>Prosperi</surname><given-names>M</given-names></name></person-group><article-title>Reported Adverse Events with painkillers: data mining of the US food and drug administration Adverse Events reporting system</article-title><source>Drug Saf</source><year>2018</year><volume>41</volume><fpage>313</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1007/s40264-017-0611-5</pub-id><pub-id pub-id-type="pmid">29098610</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_047"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodder</surname><given-names>SL</given-names></name><name name-style="western"><surname>Feinberg</surname><given-names>J</given-names></name><name name-style="western"><surname>Strathdee</surname><given-names>SA</given-names></name><name name-style="western"><surname>Shoptaw</surname><given-names>S</given-names></name><name name-style="western"><surname>Altice</surname><given-names>FL</given-names></name><name name-style="western"><surname>Ortenzio</surname><given-names>L</given-names></name><etal/></person-group><article-title>The opioid crisis and HIV in the USA: deadly synergies</article-title><source>Lancet</source><year>2021</year><volume>397</volume><fpage>1139</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00391-3</pub-id><pub-id pub-id-type="pmid">33617769</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_048"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaye</surname><given-names>AD</given-names></name><name name-style="western"><surname>Jones</surname><given-names>MR</given-names></name><name name-style="western"><surname>Kaye</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ripoll</surname><given-names>JG</given-names></name><name name-style="western"><surname>Galan</surname><given-names>V</given-names></name><name name-style="western"><surname>Beakley</surname><given-names>BD</given-names></name><etal/></person-group><article-title>Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: Part 1</article-title><source>Pain Physician</source><year>2017</year><volume>20</volume><fpage>S93</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.36076/ppj.2017.s109</pub-id><pub-id pub-id-type="pmid">28226333</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_049"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bresett</surname><given-names>JW</given-names></name><name name-style="western"><surname>Kruse-Diehr</surname><given-names>A</given-names></name></person-group><article-title>J. Medications for opioid use disorder in rural United States: a critical review of the literature, 2004&#8211;2021</article-title><source>Subst Use Misuse</source><year>2023</year><volume>58</volume><fpage>111</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1080/10826084.2022.2149244</pub-id><pub-id pub-id-type="pmid">36420639</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_050"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>HG</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>KUS</given-names></name></person-group><article-title>Survey of factors associated with adherence to standard of care in treating pregnant women with opioid use disorder</article-title><source>J Psychosom Obstet Gynaecol</source><year>2020</year><volume>41</volume><fpage>74</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1080/0167482x.2019.1634048</pub-id><pub-id pub-id-type="pmid">31244358</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_051"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grecco</surname><given-names>GG</given-names></name><name name-style="western"><surname>Mork</surname><given-names>BE</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Metzger</surname><given-names>CE</given-names></name><name name-style="western"><surname>Haggerty</surname><given-names>DL</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>KC</given-names></name><etal/></person-group><article-title>Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry</article-title><source>Elife</source><year>2021</year><volume>10</volume><fpage>1</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.7554/eLife.66230</pub-id><pub-id pub-id-type="pmcid">PMC7993998</pub-id><pub-id pub-id-type="pmid">33724184</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_052"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alipio</surname><given-names>JB</given-names></name><name name-style="western"><surname>Riggs</surname><given-names>LM</given-names></name><name name-style="western"><surname>Plank</surname><given-names>M</given-names></name><name name-style="western"><surname>Keller</surname><given-names>A</given-names></name></person-group><article-title>Environmental enrichment mitigates the long-lasting sequelae of perinatal fentanyl exposure in mice</article-title><source>J Neurosci</source><year>2022</year><volume>42</volume><fpage>3557</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1523/jneurosci.2083-21.2022</pub-id><pub-id pub-id-type="pmid">35332082</pub-id><pub-id pub-id-type="pmcid">PMC9053848</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_053"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alipio</surname><given-names>JB</given-names></name><name name-style="western"><surname>Haga</surname><given-names>C</given-names></name><name name-style="western"><surname>Fox</surname><given-names>ME</given-names></name><name name-style="western"><surname>Arakawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Balaji</surname><given-names>R</given-names></name><name name-style="western"><surname>Cramer</surname><given-names>N</given-names></name><etal/></person-group><article-title>Perinatal fentanyl exposure leads to long-lasting impairments in somatosensory circuit function and behavior</article-title><source>J Neurosci</source><year>2021</year><volume>41</volume><fpage>3400</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1523/jneurosci.2470-20.2020</pub-id><pub-id pub-id-type="pmid">33853934</pub-id><pub-id pub-id-type="pmcid">PMC8051687</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_054"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>BL</given-names></name><name name-style="western"><surname>Guzman</surname><given-names>TA</given-names></name><name name-style="western"><surname>Brendle</surname><given-names>AH</given-names></name><name name-style="western"><surname>Laaker</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ford</surname><given-names>A</given-names></name><name name-style="western"><surname>Hiltz</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Perinatal morphine exposure leads to sex-dependent executive function deficits and microglial changes in mice</article-title><source>eNeuro</source><year>2022</year><volume>9</volume><fpage>0238</fpage><lpage>22</lpage><year>2022</year><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1523/eneuro.0238-22.2022</pub-id><pub-id pub-id-type="pmcid">PMC9581576</pub-id><pub-id pub-id-type="pmid">36216505</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_055"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>SE</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>MJ</given-names></name></person-group><article-title>Effect of perinatal buprenorphine exposure on development in the rat</article-title><source>J Pharmacol Exp Ther</source><year>2001</year><volume>298</volume><fpage>797</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">11454944</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_056"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghafari</surname><given-names>M</given-names></name><name name-style="western"><surname>Kelishadi</surname><given-names>R</given-names></name><name name-style="western"><surname>Amiri</surname><given-names>M</given-names></name></person-group><article-title>Can Barker&#8217;s hypothesis explain the observed different trends of mortality from atherosclerotic cardiovascular disease in Western europe?</article-title><source>Int J Prev Med</source><year>2013</year><volume>4</volume><fpage>1229</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">24404354</pub-id><pub-id pub-id-type="pmcid">PMC3883244</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retraction-forward" ext-link-type="pmc" xlink:href="PMC4124574"/></element-citation></ref><ref id="j_nipt-2023-0017_ref_057"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Weimer</surname><given-names>RM</given-names></name><name name-style="western"><surname>McLaughlin</surname><given-names>T</given-names></name><name name-style="western"><surname>Kallop</surname><given-names>D</given-names></name><name name-style="western"><surname>Stanger</surname><given-names>K</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>A caspase cascade regulating developmental axon degeneration</article-title><source>J Neurosci</source><year>2012</year><volume>32</volume><fpage>17540</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1523/jneurosci.3012-12.2012</pub-id><pub-id pub-id-type="pmid">23223278</pub-id><pub-id pub-id-type="pmcid">PMC3532512</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_058"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamilton</surname><given-names>KL</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>LTM</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><name name-style="western"><surname>Schrott</surname><given-names>LM</given-names></name></person-group><article-title>Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1&#946;</article-title><source>Brain Res</source><year>2007</year><volume>1133</volume><fpage>92</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2006.11.044</pub-id><pub-id pub-id-type="pmid">17196563</pub-id><pub-id pub-id-type="pmcid">PMC2701894</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_059"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>VX</given-names></name><name name-style="western"><surname>Patel</surname><given-names>S</given-names></name><name name-style="western"><surname>Jones</surname><given-names>HF</given-names></name><name name-style="western"><surname>Dale</surname><given-names>RC</given-names></name></person-group><article-title>Maternal immune activation and neuroinflammation in human neurodevelopmental disorders</article-title><source>Nat Rev Neurol</source><year>2021</year><volume>17</volume><fpage>564</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/s41582-021-00530-8</pub-id><pub-id pub-id-type="pmid">34341569</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_060"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pendyala</surname><given-names>G</given-names></name><name name-style="western"><surname>Chou</surname><given-names>S</given-names></name><name name-style="western"><surname>Jung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Coiro</surname><given-names>P</given-names></name><name name-style="western"><surname>Spartz</surname><given-names>E</given-names></name><name name-style="western"><surname>Padmashri</surname><given-names>R</given-names></name><etal/></person-group><article-title>Maternal immune activation causes behavioral impairments and altered cerebellar cytokine and synaptic Protein expression</article-title><source>Neuropsychopharmacology</source><year>2017</year><volume>42</volume><fpage>1435</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/npp.2017.7</pub-id><pub-id pub-id-type="pmid">28102228</pub-id><pub-id pub-id-type="pmcid">PMC5436129</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_061"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cie&#347;lik</surname><given-names>M</given-names></name><name name-style="western"><surname>G&#261;ssowska-Dobrowolska</surname><given-names>M</given-names></name><name name-style="western"><surname>J&#281;&#347;ko</surname><given-names>H</given-names></name><name name-style="western"><surname>Czapski</surname><given-names>GA</given-names></name><name name-style="western"><surname>Wilkaniec</surname><given-names>A</given-names></name><name name-style="western"><surname>Zawadzka</surname><given-names>A</given-names></name><etal/></person-group><article-title>Maternal immune activation induces neuroinflammation and cortical synaptic deficits in the adolescent rat offspring</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><fpage>4097</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.3390/ijms21114097</pub-id><pub-id pub-id-type="pmid">32521803</pub-id><pub-id pub-id-type="pmcid">PMC7312084</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_062"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Purves-Tyson</surname><given-names>TD</given-names></name><name name-style="western"><surname>Weber-Stadlbauer</surname><given-names>U</given-names></name><name name-style="western"><surname>Richetto</surname><given-names>J</given-names></name><name name-style="western"><surname>Rothmond</surname><given-names>DA</given-names></name><name name-style="western"><surname>Labouesse</surname><given-names>MA</given-names></name><name name-style="western"><surname>Polesel</surname><given-names>M</given-names></name><etal/></person-group><article-title>Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation</article-title><source>Mol Psychiatr</source><year>2021</year><volume>26</volume><fpage>849</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/s41380-019-0434-0</pub-id><pub-id pub-id-type="pmcid">PMC7910216</pub-id><pub-id pub-id-type="pmid">31168068</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_063"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jantzie</surname><given-names>LL</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>JR</given-names></name><name name-style="western"><surname>Newville</surname><given-names>JC</given-names></name><name name-style="western"><surname>Yellowhair</surname><given-names>TR</given-names></name><name name-style="western"><surname>Kitase</surname><given-names>Y</given-names></name><name name-style="western"><surname>Madurai</surname><given-names>N</given-names></name><etal/></person-group><article-title>Prenatal opioid exposure: the next neonatal neuroinflammatory disease</article-title><source>Brain Behav Immun</source><year>2020</year><volume>84</volume><fpage>45</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2019.11.007</pub-id><pub-id pub-id-type="pmid">31765790</pub-id><pub-id pub-id-type="pmcid">PMC7010550</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_064"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>BL</given-names></name><name name-style="western"><surname>Laaker</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Lloyd</surname><given-names>KR</given-names></name><name name-style="western"><surname>Hiltz</surname><given-names>AR</given-names></name><name name-style="western"><surname>Reyes</surname><given-names>TM</given-names></name></person-group><article-title>Adolescent microglia play a role in executive function in male mice exposed to perinatal high fat diet</article-title><source>Brain Behav Immun</source><year>2020</year><volume>84</volume><fpage>80</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2019.11.010</pub-id><pub-id pub-id-type="pmid">31765789</pub-id><pub-id pub-id-type="pmcid">PMC8634520</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_065"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maltese</surname><given-names>A</given-names></name><name name-style="western"><surname>Gallai</surname><given-names>B</given-names></name><name name-style="western"><surname>Marotta</surname><given-names>R</given-names></name><name name-style="western"><surname>Lavano</surname><given-names>F</given-names></name><name name-style="western"><surname>Lavano</surname><given-names>SM</given-names></name><name name-style="western"><surname>Tripi</surname><given-names>G</given-names></name><etal/></person-group><article-title>The Synactive theory of development: the keyword for neurodevelopmental disorders</article-title><source>Acta Med Mediterr</source><year>2017</year><volume>33</volume><fpage>1257</fpage><lpage>63</lpage></element-citation></ref><ref id="j_nipt-2023-0017_ref_066"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Als</surname><given-names>H</given-names></name></person-group><article-title>Toward a synactive theory of development: promise for the assessment and support of infant individuality</article-title><source>Infant Ment Health J</source><year>1982</year><volume>3</volume><fpage>229</fpage><lpage>43</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-0355(198224)3:4&amp;#x0003c;229::aid-imhj2280030405&amp;#x0003e;3.0.co;2-h</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_067"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wishart</surname><given-names>TM</given-names></name><name name-style="western"><surname>Parson</surname><given-names>SH</given-names></name><name name-style="western"><surname>Gillingwater</surname><given-names>TH</given-names></name></person-group><article-title>Synaptic vulnerability in neurodegenerative disease</article-title><source>J Neuropathol Exp Neurol</source><year>2006</year><volume>65</volume><fpage>733</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/01.jnen.0000228202.35163.c4</pub-id><pub-id pub-id-type="pmid">16896307</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_068"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilton</surname><given-names>DK</given-names></name><name name-style="western"><surname>Dissing-Olesen</surname><given-names>L</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>B</given-names></name></person-group><article-title>Neuron-glia signaling in synapse elimination</article-title><source>Annu Rev Neurosci</source><year>2019</year><volume>42</volume><fpage>107</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-070918-050306</pub-id><pub-id pub-id-type="pmid">31283900</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_069"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tau</surname><given-names>GZ</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>BS</given-names></name></person-group><article-title>Normal development of brain circuits</article-title><source>Neuropsychopharmacology</source><year>2010</year><volume>35</volume><fpage>147</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/npp.2009.115</pub-id><pub-id pub-id-type="pmid">19794405</pub-id><pub-id pub-id-type="pmcid">PMC3055433</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_070"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Constans</surname><given-names>A</given-names></name><name name-style="western"><surname>Pin-Barre</surname><given-names>C</given-names></name><name name-style="western"><surname>Temprado</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Decherchi</surname><given-names>P</given-names></name><name name-style="western"><surname>Laurin</surname><given-names>J</given-names></name></person-group><article-title>Influence of aerobic training and combinations of interventions on cognition and neuroplasticity after stroke</article-title><source>Front Aging Neurosci</source><year>2016</year><volume>8</volume><fpage>164</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2016.00164</pub-id><pub-id pub-id-type="pmid">27445801</pub-id><pub-id pub-id-type="pmcid">PMC4928497</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_071"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Todorova</surname><given-names>V</given-names></name><name name-style="western"><surname>Blokland</surname><given-names>A</given-names></name></person-group><article-title>Mitochondria and synaptic plasticity in the mature and aging nervous system</article-title><source>Curr Neuropharmacol</source><year>2017</year><volume>15</volume><fpage>166</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.2174/1570159x14666160414111821</pub-id><pub-id pub-id-type="pmid">27075203</pub-id><pub-id pub-id-type="pmcid">PMC5327446</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_072"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Runge</surname><given-names>K</given-names></name><name name-style="western"><surname>Cardoso</surname><given-names>C</given-names></name><name name-style="western"><surname>de Chevigny</surname><given-names>A</given-names></name></person-group><article-title>Dendritic spine plasticity: function and mechanisms</article-title><source>Front Synaptic Neurosci</source><year>2020</year><volume>12</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.3389/fnsyn.2020.00036</pub-id><pub-id pub-id-type="pmid">32982715</pub-id><pub-id pub-id-type="pmcid">PMC7484486</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_073"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Legault</surname><given-names>J</given-names></name><name name-style="western"><surname>Litcofsky</surname><given-names>KA</given-names></name></person-group><article-title>Neuroplasticity as a function of second language learning: anatomical changes in the human brain</article-title><source>Cortex</source><year>2014</year><volume>58</volume><fpage>301</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.cortex.2014.05.001</pub-id><pub-id pub-id-type="pmid">24996640</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_074"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C-C</given-names></name><name name-style="western"><surname>Hung</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Shen</surname><given-names>CH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Pan</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Prenatal buprenorphine exposure decreases neurogenesis in rats</article-title><source>Toxicol Lett</source><year>2014</year><volume>225</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2013.12.001</pub-id><pub-id pub-id-type="pmid">24321744</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_075"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>C-J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Kuan</surname><given-names>YH</given-names></name><name name-style="western"><surname>Pan</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Depression-like effect of prenatal buprenorphine exposure in rats</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><elocation-id>e82262</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0082262</pub-id><pub-id pub-id-type="pmid">24367510</pub-id><pub-id pub-id-type="pmcid">PMC3867331</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_076"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schilling</surname><given-names>S</given-names></name><name name-style="western"><surname>Chausse</surname><given-names>B</given-names></name><name name-style="western"><surname>Dikmen</surname><given-names>HO</given-names></name><name name-style="western"><surname>Almouhanna</surname><given-names>F</given-names></name><name name-style="western"><surname>Hollnagel</surname><given-names>JO</given-names></name><name name-style="western"><surname>Lewen</surname><given-names>A</given-names></name><etal/></person-group><article-title>TLR2- and TLR3-activated microglia induce different levels of neuronal network dysfunction in a context-dependent manner</article-title><source>Brain Behav Immun</source><year>2021</year><volume>96</volume><fpage>80</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2021.05.013</pub-id><pub-id pub-id-type="pmid">34015428</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_077"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>CC</given-names></name><name name-style="western"><surname>Hung</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Lin</surname><given-names>SY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WY</given-names></name><etal/></person-group><article-title>Treadmill exercise alleviated prenatal buprenorphine exposure-induced depression in rats</article-title><source>Neurochem Int</source><year>2017</year><volume>110</volume><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2017.09.012</pub-id><pub-id pub-id-type="pmid">28962922</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_078"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores</surname><given-names>A</given-names></name></person-group><article-title>Neurobehavioral characterization of perinatal oxycodone-exposed offspring in early adolesence</article-title><source>Brain Behav Immun</source><year>2023</year><comment>in Review</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11481-024-10129-7</pub-id><pub-id pub-id-type="pmid">38874861</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_079"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newville</surname><given-names>J</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>JR</given-names></name><name name-style="western"><surname>Kitase</surname><given-names>Y</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>S</given-names></name><name name-style="western"><surname>Jantzie</surname><given-names>LL</given-names></name></person-group><article-title>Perinatal opioid exposure primes the peripheral immune system toward hyperreactivity</article-title><source>Front Pediatr</source><year>2020</year><volume>8</volume><fpage>272</fpage><pub-id pub-id-type="doi">10.3389/fped.2020.00272</pub-id><pub-id pub-id-type="pmid">32670993</pub-id><pub-id pub-id-type="pmcid">PMC7332770</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_080"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thangaraj</surname><given-names>A</given-names></name><name name-style="western"><surname>Periyasamy</surname><given-names>P</given-names></name><name name-style="western"><surname>Liao</surname><given-names>K</given-names></name><name name-style="western"><surname>Bendi</surname><given-names>VS</given-names></name><name name-style="western"><surname>Callen</surname><given-names>S</given-names></name><name name-style="western"><surname>Pendyala</surname><given-names>G</given-names></name><etal/></person-group><article-title>HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy</article-title><source>Autophagy</source><year>2018</year><volume>14</volume><fpage>1596</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1080/15548627.2018.1476810</pub-id><pub-id pub-id-type="pmid">29966509</pub-id><pub-id pub-id-type="pmcid">PMC6135576</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_081"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chaillon</surname><given-names>A</given-names></name><name name-style="western"><surname>Gianella</surname><given-names>S</given-names></name><name name-style="western"><surname>Wong</surname><given-names>LM</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Simermeyer</surname><given-names>TL</given-names></name><etal/></person-group><article-title>Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy</article-title><source>J Clin Invest</source><year>2023</year><volume>133</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1172/jci167417</pub-id><pub-id pub-id-type="pmcid">PMC10266791</pub-id><pub-id pub-id-type="pmid">37317962</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_082"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McMillan</surname><given-names>RE</given-names></name><name name-style="western"><surname>Wang</surname><given-names>E</given-names></name><name name-style="western"><surname>Carlin</surname><given-names>AF</given-names></name><name name-style="western"><surname>Coufal</surname><given-names>NG</given-names></name></person-group><article-title>Human microglial models to study host-virus interactions</article-title><source>Exp Neurol</source><year>2023</year><volume>363</volume><elocation-id>114375</elocation-id><pub-id pub-id-type="doi">10.1016/j.expneurol.2023.114375</pub-id><pub-id pub-id-type="pmid">36907350</pub-id><pub-id pub-id-type="pmcid">PMC10521930</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_083"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gornalusse</surname><given-names>GG</given-names></name><name name-style="western"><surname>Vojtech</surname><given-names>LN</given-names></name><name name-style="western"><surname>Levy</surname><given-names>CN</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>SM</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Valdez</surname><given-names>R</given-names></name><etal/></person-group><article-title>Buprenorphine increases HIV-1 infection in vitro but does not reactivate HIV-1 from latency</article-title><source>Viruses</source><year>2021</year><volume>13</volume><fpage>1472</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.3390/v13081472</pub-id><pub-id pub-id-type="pmid">34452338</pub-id><pub-id pub-id-type="pmcid">PMC8402857</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_084"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores</surname><given-names>A</given-names></name><name name-style="western"><surname>Gowen</surname><given-names>A</given-names></name><name name-style="western"><surname>Schaal</surname><given-names>VL</given-names></name><name name-style="western"><surname>Koul</surname><given-names>S</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>JB</given-names></name><name name-style="western"><surname>Yelamanchili</surname><given-names>SV</given-names></name><etal/></person-group><article-title>Impact of adolescent nicotine exposure in pre- and post-natal oxycodone exposed offspring</article-title><source>J Neuroimmune Pharmacol</source><year>2023</year><volume>18</volume><fpage>312</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1007/s11481-023-10074-x</pub-id><pub-id pub-id-type="pmid">37351737</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_085"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noursi</surname><given-names>S</given-names></name><name name-style="western"><surname>Saluja</surname><given-names>B</given-names></name><name name-style="western"><surname>Richey</surname><given-names>L</given-names></name></person-group><article-title>Using the ecological systems theory to understand black/white disparities in maternal morbidity and mortality in the United States</article-title><source>J Racial Ethn Health Disparities</source><year>2021</year><volume>8</volume><fpage>661</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s40615-020-00825-4</pub-id><pub-id pub-id-type="pmid">32720294</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_086"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schiff</surname><given-names>DM</given-names></name><name name-style="western"><surname>Work</surname><given-names>EC</given-names></name><name name-style="western"><surname>Foley</surname><given-names>B</given-names></name><name name-style="western"><surname>Applewhite</surname><given-names>R</given-names></name><name name-style="western"><surname>Diop</surname><given-names>H</given-names></name><name name-style="western"><surname>Goullaud</surname><given-names>L</given-names></name><etal/></person-group><article-title>Perinatal opioid use disorder research, race, and racism: a scoping review</article-title><source>Pediatrics</source><year>2022</year><volume>149</volume><fpage>1</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1542/peds.2021-052368</pub-id><pub-id pub-id-type="pmcid">PMC9044279</pub-id><pub-id pub-id-type="pmid">35156121</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_087"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hwang</surname><given-names>SS</given-names></name><name name-style="western"><surname>Weikel</surname><given-names>B</given-names></name><name name-style="western"><surname>Adams</surname><given-names>J</given-names></name><name name-style="western"><surname>Bourque</surname><given-names>SL</given-names></name><name name-style="western"><surname>Cabrera</surname><given-names>J</given-names></name><name name-style="western"><surname>Griffith</surname><given-names>N</given-names></name><etal/></person-group><article-title>The Colorado hospitals substance exposed newborn quality improvement collaborative: standardization of care for opioid-exposed newborns shortens length of stay and reduces number of infants requiring opiate therapy</article-title><source>Hosp Pediatr</source><year>2020</year><volume>10</volume><fpage>783</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1542/hpeds.2020-0032</pub-id><pub-id pub-id-type="pmid">32769086</pub-id><pub-id pub-id-type="pmcid">PMC7446548</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_088"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amiri</surname><given-names>S</given-names></name><name name-style="western"><surname>Nair</surname><given-names>J</given-names></name></person-group><article-title>Gestational age alters assessment of neonatal abstinence syndrome</article-title><source>Pediatr Rep</source><year>2022</year><volume>14</volume><fpage>50</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.3390/pediatric14010009</pub-id><pub-id pub-id-type="pmid">35225878</pub-id><pub-id pub-id-type="pmcid">PMC8883891</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_089"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grecco</surname><given-names>GG</given-names></name><name name-style="western"><surname>Shahid</surname><given-names>SS</given-names></name><name name-style="western"><surname>Atwood</surname><given-names>BK</given-names></name><name name-style="western"><surname>Wu</surname><given-names>YC</given-names></name></person-group><article-title>Alterations of brain microstructures in a mouse model of prenatal opioid exposure detected by diffusion MRI</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><elocation-id>17085</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-21416-9</pub-id><pub-id pub-id-type="pmid">36224335</pub-id><pub-id pub-id-type="pmcid">PMC9556691</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_090"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grecco</surname><given-names>GG</given-names></name><name name-style="western"><surname>Atwood</surname><given-names>BK</given-names></name></person-group><article-title>Prenatal opioid exposure enhances responsiveness to future drug reward and alters sensitivity to pain: a review of preclinical models and contributing mechanisms</article-title><source>eNeuro</source><year>2020</year><volume>7</volume><pub-id pub-id-type="doi">10.1523/eneuro.0393-20.2020</pub-id><pub-id pub-id-type="pmcid">PMC7768284</pub-id><pub-id pub-id-type="pmid">33060181</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_091"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radhakrishnan</surname><given-names>R</given-names></name><name name-style="western"><surname>Grecco</surname><given-names>G</given-names></name><name name-style="western"><surname>Stolze</surname><given-names>K</given-names></name><name name-style="western"><surname>Atwood</surname><given-names>B</given-names></name><name name-style="western"><surname>Jennings</surname><given-names>SG</given-names></name><name name-style="western"><surname>Lien</surname><given-names>IZ</given-names></name><etal/></person-group><article-title>Neuroimaging in infants with prenatal opioid exposure: current evidence, recent developments and targets for future research</article-title><source>J Neuroradiol</source><year>2021</year><volume>48</volume><fpage>112</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.neurad.2020.09.009</pub-id><pub-id pub-id-type="pmid">33065196</pub-id><pub-id pub-id-type="pmcid">PMC7979441</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_092"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chin</surname><given-names>EM</given-names></name><name name-style="western"><surname>Kitase</surname><given-names>Y</given-names></name><name name-style="western"><surname>Madurai</surname><given-names>NK</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>S</given-names></name><name name-style="western"><surname>Jantzie</surname><given-names>LL</given-names></name></person-group><article-title>In utero methadone exposure permanently alters anatomical and functional connectivity: a preclinical evaluation</article-title><source>Front Pediatr</source><year>2023</year><volume>11</volume><elocation-id>1139378</elocation-id><pub-id pub-id-type="doi">10.3389/fped.2023.1139378</pub-id><pub-id pub-id-type="pmid">36911026</pub-id><pub-id pub-id-type="pmcid">PMC9995894</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_093"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahjin</surname><given-names>F</given-names></name><name name-style="western"><surname>Guda</surname><given-names>RS</given-names></name><name name-style="western"><surname>Schaal</surname><given-names>VL</given-names></name><name name-style="western"><surname>Odegaard</surname><given-names>K</given-names></name><name name-style="western"><surname>Clark</surname><given-names>A</given-names></name><name name-style="western"><surname>Gowen</surname><given-names>A</given-names></name><etal/></person-group><article-title>Brain-derived extracellular vesicle microRNA signatures associated with in utero and postnatal oxycodone exposure</article-title><source>Cells</source><year>2019</year><volume>9</volume><fpage>21</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.3390/cells9010021</pub-id><pub-id pub-id-type="pmid">31861723</pub-id><pub-id pub-id-type="pmcid">PMC7016745</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_094"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Odegaard</surname><given-names>KE</given-names></name><name name-style="western"><surname>Schaal</surname><given-names>VL</given-names></name><name name-style="western"><surname>Clark</surname><given-names>AR</given-names></name><name name-style="western"><surname>Koul</surname><given-names>S</given-names></name><name name-style="western"><surname>Gowen</surname><given-names>A</given-names></name><name name-style="western"><surname>Sankarasubramani</surname><given-names>J</given-names></name><etal/></person-group><article-title>Characterization of the intergenerational impact of in utero and postnatal oxycodone exposure</article-title><source>Transl Psychiatry</source><year>2020</year><volume>10</volume><fpage>329</fpage><pub-id pub-id-type="doi">10.1038/s41398-020-01012-z</pub-id><pub-id pub-id-type="pmid">32968044</pub-id><pub-id pub-id-type="pmcid">PMC7511347</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_095"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Odegaard</surname><given-names>KE</given-names></name><name name-style="western"><surname>Schaal</surname><given-names>VL</given-names></name><name name-style="western"><surname>Clark</surname><given-names>AR</given-names></name><name name-style="western"><surname>Koul</surname><given-names>S</given-names></name><name name-style="western"><surname>Sankarasubramanian</surname><given-names>J</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Z</given-names></name><etal/></person-group><article-title>A holistic systems approach to characterize the impact of pre- and post-natal oxycodone exposure on neurodevelopment and behavior</article-title><source>Front Cell Dev Biol</source><year>2020</year><volume>8</volume><elocation-id>619199</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2020.619199</pub-id><pub-id pub-id-type="pmid">33490084</pub-id><pub-id pub-id-type="pmcid">PMC7817773</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_096"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gowen</surname><given-names>AM</given-names></name><name name-style="western"><surname>Yi</surname><given-names>J</given-names></name><name name-style="western"><surname>Stauch</surname><given-names>K</given-names></name><name name-style="western"><surname>Miles</surname><given-names>L</given-names></name><name name-style="western"><surname>Srinivasan</surname><given-names>S</given-names></name><name name-style="western"><surname>Odegaard</surname><given-names>K</given-names></name><etal/></person-group><article-title>In utero and post-natal opioid exposure followed by mild traumatic brain injury contributes to cortical neuroinflammation, mitochondrial dysfunction, and behavioral deficits in juvenile rats</article-title><source>Brain Behav Immun</source><year>2023</year><volume>32</volume><fpage>100669</fpage><pub-id pub-id-type="doi">10.1016/j.bbih.2023.100669</pub-id><pub-id pub-id-type="pmcid">PMC10425912</pub-id><pub-id pub-id-type="pmid">37588011</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_097"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byrnes</surname><given-names>EM</given-names></name></person-group><article-title>Transgenerational consequences of adolescent morphine exposure in female rats: effects on anxiety-like behaviors and morphine sensitization in adult offspring</article-title><source>Psychopharmacology</source><year>2005</year><volume>182</volume><fpage>537</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1007/s00213-005-0122-4</pub-id><pub-id pub-id-type="pmid">16163528</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_098"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byrnes</surname><given-names>EM</given-names></name><name name-style="western"><surname>Vassoler</surname><given-names>FM</given-names></name></person-group><article-title>Modeling prenatal opioid exposure in animals: current findings and future directions</article-title><source>Front Neuroendocrinol</source><year>2018</year><volume>51</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.yfrne.2017.09.001</pub-id><pub-id pub-id-type="pmid">28965857</pub-id><pub-id pub-id-type="pmcid">PMC5649358</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_099"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byrnes</surname><given-names>EM</given-names></name></person-group><article-title>Chronic morphine exposure during puberty decreases postpartum prolactin secretion in adult female rats</article-title><source>Pharmacol Biochem Behav</source><year>2005</year><volume>80</volume><fpage>445</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.pbb.2004.12.011</pub-id><pub-id pub-id-type="pmid">15740787</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamilton</surname><given-names>KL</given-names></name><name name-style="western"><surname>Harris</surname><given-names>AC</given-names></name><name name-style="western"><surname>Gewirtz</surname><given-names>JC</given-names></name><name name-style="western"><surname>Sparber</surname><given-names>SB</given-names></name><name name-style="western"><surname>Schrott</surname><given-names>LM</given-names></name></person-group><article-title>HPA axis dysregulation following prenatal opiate exposure and postnatal withdrawal</article-title><source>Neurotoxicol Teratol</source><year>2005</year><volume>27</volume><fpage>95</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.ntt.2004.09.004</pub-id><pub-id pub-id-type="pmid">15681124</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castellano</surname><given-names>C</given-names></name><name name-style="western"><surname>Ammassari-Teule</surname><given-names>M</given-names></name></person-group><article-title>Prenatal exposure to morphine in mice: enhanced responsiveness to morphine and stress</article-title><source>Pharmacol Biochem Behav</source><year>1984</year><volume>21</volume><fpage>103</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/0091-3057(84)90138-2</pub-id><pub-id pub-id-type="pmid">6540449</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klausz</surname><given-names>B</given-names></name><name name-style="western"><surname>Pint&#233;r</surname><given-names>O</given-names></name><name name-style="western"><surname>Sobor</surname><given-names>M</given-names></name><name name-style="western"><surname>Gyarmati</surname><given-names>Z</given-names></name><name name-style="western"><surname>F&#252;rst</surname><given-names>Z</given-names></name><name name-style="western"><surname>T&#237;m&#225;r</surname><given-names>J</given-names></name><etal/></person-group><article-title>Changes in adaptability following perinatal morphine exposure in juvenile and adult rats</article-title><source>Eur J Pharmacol</source><year>2011</year><volume>654</volume><fpage>166</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2010.11.025</pub-id><pub-id pub-id-type="pmid">21147096</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sithisarn</surname><given-names>T</given-names></name><name name-style="western"><surname>Legan</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Westgate</surname><given-names>PM</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>M</given-names></name><name name-style="western"><surname>Wellmann</surname><given-names>K</given-names></name><name name-style="western"><surname>Bada</surname><given-names>HS</given-names></name><etal/></person-group><article-title>The effects of perinatal oxycodone exposure on behavioral outcome in a rodent model</article-title><source>Front Pediatr</source><year>2017</year><volume>5</volume><fpage>180</fpage><pub-id pub-id-type="doi">10.3389/fped.2017.00180</pub-id><pub-id pub-id-type="pmid">28971091</pub-id><pub-id pub-id-type="pmcid">PMC5609564</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zanni</surname><given-names>G</given-names></name><name name-style="western"><surname>Robinson-Drummer</surname><given-names>PA</given-names></name><name name-style="western"><surname>Dougher</surname><given-names>AA</given-names></name><name name-style="western"><surname>Deutsch</surname><given-names>HM</given-names></name><name name-style="western"><surname>DeSalle</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Teplitsky</surname><given-names>D</given-names></name><etal/></person-group><article-title>Maternal continuous oral oxycodone self-administration alters pup affective/social communication but not spatial learning or sensory-motor function</article-title><source>Drug Alcohol Depend</source><year>2021</year><volume>221</volume><elocation-id>108628</elocation-id><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.108628</pub-id><pub-id pub-id-type="pmid">33761428</pub-id><pub-id pub-id-type="pmcid">PMC10787952</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>SA</given-names></name><name name-style="western"><surname>Jones</surname><given-names>AD</given-names></name><name name-style="western"><surname>Brynildsen</surname><given-names>JK</given-names></name><name name-style="western"><surname>Ehrlich</surname><given-names>ME</given-names></name><name name-style="western"><surname>Blendy</surname><given-names>JA</given-names></name></person-group><article-title>Neurobehavioral effects of neonatal opioid exposure in mice: influence of the OPRM1 SNP</article-title><source>Addict Biol</source><year>2020</year><volume>25</volume><elocation-id>e12806</elocation-id><pub-id pub-id-type="doi">10.1111/adb.12806</pub-id><pub-id pub-id-type="pmid">31267641</pub-id><pub-id pub-id-type="pmcid">PMC8450766</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vassoler</surname><given-names>FM</given-names></name><name name-style="western"><surname>Oranges</surname><given-names>ML</given-names></name><name name-style="western"><surname>Toorie</surname><given-names>AM</given-names></name><name name-style="western"><surname>Byrnes</surname><given-names>EM</given-names></name></person-group><article-title>Oxycodone self-administration during pregnancy disrupts the maternal-infant dyad and decreases midbrain OPRM1 expression during early postnatal development in rats</article-title><source>Pharmacol Biochem Behav</source><year>2018</year><volume>173</volume><fpage>74</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.pbb.2018.07.009</pub-id><pub-id pub-id-type="pmid">30055180</pub-id><pub-id pub-id-type="pmcid">PMC6126918</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shapiro</surname><given-names>LE</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>ME</given-names></name><name name-style="western"><surname>Dewsbury</surname><given-names>DA</given-names></name></person-group><article-title>Affiliative behavior in voles: effects of morphine, naloxone, and cross-fostering</article-title><source>Physiol Behav</source><year>1989</year><volume>46</volume><fpage>719</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/0031-9384(89)90357-0</pub-id><pub-id pub-id-type="pmid">2557648</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kai</surname><given-names>S</given-names></name><name name-style="western"><surname>Kohmura</surname><given-names>H</given-names></name><name name-style="western"><surname>Ishikawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Kadota</surname><given-names>T</given-names></name><name name-style="western"><surname>Kawano</surname><given-names>S</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>N</given-names></name></person-group><article-title>Effect of butorphanol tartrate on cross-fostering in rats</article-title><source>Nihon Yakurigaku Zasshi</source><year>1984</year><volume>83</volume><fpage>115</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1254/fpj.83.115</pub-id><pub-id pub-id-type="pmid">6745803</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akbarabadi</surname><given-names>A</given-names></name><name name-style="western"><surname>Sadat-Shirazi</surname><given-names>MS</given-names></name><name name-style="western"><surname>Kabbaj</surname><given-names>M</given-names></name><name name-style="western"><surname>Nouri Zadeh-Tehrani</surname><given-names>S</given-names></name><name name-style="western"><surname>Khalifeh</surname><given-names>S</given-names></name><name name-style="western"><surname>Pirri</surname><given-names>F</given-names></name><etal/></person-group><article-title>Effects of morphine and maternal care on behaviors and Protein expression of male offspring</article-title><source>Neuroscience</source><year>2021</year><volume>466</volume><fpage>58</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2021.04.011</pub-id><pub-id pub-id-type="pmid">33915201</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friedler</surname><given-names>G</given-names></name><name name-style="western"><surname>Cochin</surname><given-names>J</given-names></name></person-group><article-title>Growth retardation in offspring of female rats treated with morphine prior to conception</article-title><source>Science</source><year>1972</year><volume>175</volume><fpage>654</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1126/science.175.4022.654</pub-id><pub-id pub-id-type="pmid">5009766</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dickinson</surname><given-names>AL</given-names></name><name name-style="western"><surname>Leach</surname><given-names>MC</given-names></name><name name-style="western"><surname>Flecknell</surname><given-names>PA</given-names></name></person-group><article-title>Influence of early neonatal experience on nociceptive responses and analgesic effects in rats</article-title><source>Lab Anim</source><year>2009</year><volume>43</volume><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1258/la.2007.007078</pub-id><pub-id pub-id-type="pmid">18987062</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudakov</surname><given-names>SK</given-names></name><name name-style="western"><surname>Borisova</surname><given-names>EV</given-names></name><name name-style="western"><surname>Lyupina</surname><given-names>YV</given-names></name></person-group><article-title>Influence of inheritance and fostering on sensitivity to effects of morphine on nociception and locomotor activity in two inbred rat strains</article-title><source>Neuropharmacology</source><year>1996</year><volume>35</volume><fpage>1131</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/s0028-3908(96)00042-1</pub-id><pub-id pub-id-type="pmid">9121616</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pa&#269;esov&#225;</surname><given-names>D</given-names></name><name name-style="western"><surname>Spi&#353;sk&#225;</surname><given-names>V</given-names></name><name name-style="western"><surname>Novotn&#253;</surname><given-names>J</given-names></name><name name-style="western"><surname>Bendov&#225;</surname><given-names>Z</given-names></name></person-group><article-title>Maternal morphine intake during pregnancy and lactation affects the circadian clock of rat pups</article-title><source>Brain Res Bull</source><year>2021</year><volume>177</volume><fpage>143</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2021.09.016</pub-id><pub-id pub-id-type="pmid">34560238</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Callaghan</surname><given-names>JP</given-names></name><name name-style="western"><surname>Holtzman</surname><given-names>SG</given-names></name></person-group><article-title>Prenatal administration of morphine to the rat: tolerance to the analgesic effect of morphine in the offspring</article-title><source>J Pharmacol Exp Ther</source><year>1976</year><volume>197</volume><fpage>533</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">932990</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alipio</surname><given-names>JB</given-names></name><name name-style="western"><surname>Brockett</surname><given-names>AT</given-names></name><name name-style="western"><surname>Fox</surname><given-names>ME</given-names></name><name name-style="western"><surname>Tennyson</surname><given-names>SS</given-names></name><name name-style="western"><surname>deBettencourt</surname><given-names>CA</given-names></name><name name-style="western"><surname>El-Metwally</surname><given-names>D</given-names></name><etal/></person-group><article-title>Enduring consequences of perinatal fentanyl exposure in mice</article-title><source>Addict Biol</source><year>2021</year><volume>26</volume><elocation-id>e12895</elocation-id><pub-id pub-id-type="doi">10.1111/adb.12895</pub-id><pub-id pub-id-type="pmid">32187805</pub-id><pub-id pub-id-type="pmcid">PMC7897444</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>RE</given-names></name><name name-style="western"><surname>Green</surname><given-names>MT</given-names></name><name name-style="western"><surname>Kinkade</surname><given-names>JA</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>RR</given-names></name><name name-style="western"><surname>Willemse</surname><given-names>TE</given-names></name><name name-style="western"><surname>Schenk</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Maternal oxycodone treatment results in neurobehavioral disruptions in mice offspring</article-title><source>eNeuro</source><year>2021</year><volume>8</volume><fpage>150</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1523/eneuro.0150-21.2021</pub-id><pub-id pub-id-type="pmcid">PMC8354714</pub-id><pub-id pub-id-type="pmid">34312305</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>HE</given-names></name><name name-style="western"><surname>Kaltenbach</surname><given-names>K</given-names></name><name name-style="western"><surname>Heil</surname><given-names>SH</given-names></name><name name-style="western"><surname>Stine</surname><given-names>SM</given-names></name><name name-style="western"><surname>Coyle</surname><given-names>MG</given-names></name><name name-style="western"><surname>Arria</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Neonatal abstinence syndrome after methadone or buprenorphine exposure</article-title><source>N Engl J Med</source><year>2010</year><volume>363</volume><fpage>2320</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1005359</pub-id><pub-id pub-id-type="pmid">21142534</pub-id><pub-id pub-id-type="pmcid">PMC3073631</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>SE</given-names></name></person-group><article-title>Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny</article-title><source>Neurotoxicol Teratol</source><year>2002</year><volume>24</volume><fpage>137</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/s0892-0362(01)00185-4</pub-id><pub-id pub-id-type="pmid">11943501</pub-id></element-citation></ref><ref id="j_nipt-2023-0017_ref_119"><label>119.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></name></person-group><publisher-name>The National Institute of Drug Addiction: Congressional Justification FY 2023, N.I.o.D.A. National Institute of Health, Editor. Washington, D.C.: United States Congress - Congressional Budget Office; 2022, pp</publisher-name><fpage>1</fpage><lpage>391</lpage><source>.</source></element-citation></ref></ref-list></back></article></pmc-articleset>